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Abstract 
Caseinophosphopeptides (CPPs), bioactive peptides released from caseins, have the 
ability to enhance bivalent mineral solubility. This is relevant to numerous biological 
functions in the oral cavity (promotion of tooth enamel remineralisation, prevention of 
demineralisation and buffering of plaque pH). Therefore, CPPs may play a positive role 
as prophylactic agents for caries, enamel erosion and regression of white spot lesions. 
Most in vitro and in situ studies demonstrate strong evidence for the bioactivity of CPPs 
in the oral cavity. Nevertheless, relatively little is known concerning their use as 
adjuvants for oral health and more particularly regarding their long-term effects on oral 
health. 
Keywords: caseinophosphopeptides; CPP-ACP; remineralisation; demineralisation; 
caries; erosion. 
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1. Introduction 
1.1. The prevalence of dental caries 
The prevalence of dental caries represents a public health issue in many countries. 
Indeed, dental caries and periodontal diseases have been described as the most prevalent 
or widespread condition within humans [Petersen and Kwan, 2009]. It has been reported 
that 90% of the world’s population will experience caries at least once in their life 
[Marchisio et al., 2010]. In the USA for example, it is estimated that 90% of late 
adolescents and young adults are affected by caries while 94% of adults have coronal 
caries [Chen and Wang, 2010]. It has been proposed that early detection both in 
children and adults could allow a better management of caries [Pitts and Wefel, 2009]. 
Dental caries is defined as the destruction of tooth tissue by the action of oral micro-
organisms. The first step of the process involves demineralisation of tooth hard tissue 
by organic acids produced from fermentable carbohydrates by cariogenic bacteria 
located in dental plaque [Chen and Wang, 2010; Cross et al., 2007a; Elsayad et al., 
2009; Featherstone et al., 2011; Reynolds, 2008b, 2009]. Bacteria can colonize the tooth 
surface and adhere to the pellicle through adhesion-receptor interactions, resulting in the 
formation of biofilms [Hannig and Hannig, 2010]. A biofilm, which is defined as a 
spatial organisation of a microbial community in a polymer matrix (originating from the 
bacteria and saliva), adheres onto the tooth surface [Marsch et al., 2011]. These biofilms 
are typically referred as dental plaque. Dental plaque consists of different species of 
bacteria and a combination of polysaccharides, proteins and DNA [Chen and Wang, 
2010]. Demineralisation of tooth enamel is caused by dissolution of apatite crystals 
[Cross et al., 2006]. This in turn can lead to the appearance of lesions at the tooth 
surface. Caries incidence have significantly regressed in recent years following the 
utilisation of non-invasive interventions including the use of therapeutic agents such as 
fluorides to combat enamel demineralisation caused by bacteria located in dental plaque 
[Chen and Wang, 2010; Cross et al., 2006; Featherstone et al., 2011; Peters, 2010; 
Pradeep and Prasans, 2011]. Nevertheless caries is still a concern in some population 
groups including infants and adolescents or people who do not use oral hygiene 
products [Cross et al., 2007a; Petersen and Kwan, 2009; Rahiotis et al., 2008; Rose, 
2000]. The prevalence of dental caries has been associated with poor living conditions, 
life style (inadequate diet, tobacco, alcohol, oral hygiene) and the availability of oral 
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health services [Petersen and Kwan, 2009]. The World Health Organisation (WHO) has 
defined some priorities to decrease the incidence of dental caries worldwide, these 
include the increased utilisation of fluorides, a targeted improvement of oral hygiene in 
different age groups, development of oral health policies and promotion of oral health 
research [Petersen and Kwan, 2009]. Nevertheless, the utilisation of excessive amounts 
of fluoride can cause pathologies such as fluorosis during tooth development of young 
children. Fluorosis is caused by the ingestion of excessive amounts of fluoride which 
results in an hypomineralisation of the tooth enamel and can cause the appearance of 
white lines or brown stains depending on the severity of the symptoms [Reynolds, 1998; 
Wong et al., 2010]. Children of 9 years who received a fluoride daily intake of 0.05 mg 
F/kg until the age of 48 months had no caries and no fluorosis. Below this value, 
children developed caries and above it, they could develop fluorosis [Warren et al., 
2009]. Combinations of fluoride with other remineralising agents could help combat the 
development of dental caries in children and avoid the development of pathologies such 
as fluorosis. 
1.2. The prevalence of dental erosion 
Besides caries, dental erosion is another important issue in oral health. In recent times 
while there appears to be a decline in dental caries prevalence [Borges et al., 2011], 
more attention is now being given to dental erosion [Tantbirojn et al., 2008] as an 
increase in its prevalence has been observed [Ranjitkar et al., 2009a; Wang et al., 2011]. 
Erosion is the consequence of the contact of teeth with low pH solutions (pH 1 to 3) 
which occurs during the consumption of acidic foods and fluids, or when gastric fluids 
get into the oral cavity [Barbour et al., 2011; Hannig and Hannig, 2010; Lussi, 2009; 
Panisch and Poolthong, 2009; ten Cate, 1999; Wegehaupt and Attin, 2010]. In a recent 
review, Barbour et al. [2011] described low pH as the main factor in erosion and values 
below pH 5.0 have been reported as the threshold pH for erosion detection. Erosion can 
also be associated with parameters such as abrasive conditions during teeth cleaning or 
physiological deficiencies such as low saliva flow [Lussi, 2009]. Enhancement of the 
extent of tooth remineralisation has been proposed as a means to prevent dental erosion 
[Wegehaupt and Attin, 2010]. 
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1.3. Potential of caseinophosphopeptides (CPPs) as natural remineralising 
agents 
CPPs are casein derived phosphorylated peptides which have binding and solubilizing 
properties for a wide range of minerals such as calcium, magnesium and iron. In 
addition, CPPs may bind and solubilise other trace elements, such as zinc, barium, 
selenium, nickel, cobalt and chromium [FitzGerald, 1998]. CPPs have also been 
associated with improved dietary bioavailability of bivalent cations and as a 
consequence they may play a major role in modulating mineral uptake and bone 
formation [FitzGerald, 1998; Meisel and Frister, 1988]. Therefore, the utilization of 
CPPs to improve bone health has been the subject of much research [FitzGerald, 1998; 
Gueguen and Pointillart, 2000; Tulipano et al., 2010]. CPPs have also been associated 
with an improvement in oral health, notably for their role in promoting remineralisation 
of dental enamel, thereby combating the development of dental caries [Elsayad et al., 
2009; FitzGerald, 1998; Rehder Neto et al., 2009; Reynolds, 1997b]. There has been a 
large interest in the potential applications of CPPs over the last 30 years, following 
increased public health awareness related to the consequences of poor bone health and 
dental pathologies such as caries. With recent developments in minimally invasive 
treatments, the interest in natural remineralising agents such as CPPs are becoming 
more relevant to dentistry [Borges et al., 2011; Gupta and Prakash, 2011]. As a 
consequence, CPPs have been commercially developed as natural ingredients arising 
from milk proteins mainly for their mineral binding properties [Reynolds, 1998]. A 
significant level of potential intellectual property has been devoted to the discovery of 
new CPP sequences or the isolation and development of new CPP applications in the 
area of oral hygiene and bone health [Reynolds, 2010; Reynolds et al., 2009]. 
Nevertheless, some conflicting evidence exists in relation to the efficacy of these 
biofunctional peptides. 
The aim of this review is to critically assess current literature in relation to the role of 
CPPs in the remineralisation of teeth. Evidence for bioactivity of CPPs in the oral cavity 
will be discussed presenting information obtained in different studies carried out in 
vitro, in situ and in vivo. Special attention will be given to human intervention trials 
which have been performed to address the contradictions in relation to the bioactive 
potential of CPPs as remineralising agents in the oral cavity. The market situation will 
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also be described outlining currently available CPP containing products along with an 
overview of the patent terrain. 
2. Caseinophosphopeptides 
2.1. Structure of caseinophosphopeptides 
CPPs correspond to peptide fragments which are rich in clusters of phosphorylated seryl 
(and occasionally threonine) residues. CPPs represent approximately 10% (w/w) of the 
primary sequence of the caseins [Cross et al., 2007a; Cross et al., 2006; Swaisgood, 
1982]. Caseins are phosphorylated during milk biosynthesis via the activity of specific 
kinases present in the mammary gland [FitzGerald, 1998]. The number of 
serine/threonine phosphate groups may be influenced by genetic polymorphism of the 
proteins. Therefore, different levels of phosphorylation may be observed in the 
individual caseins as follows:  
 s1-casein: 8-9 phosphate groups 
 s2-casein: 10-13 phosphate groups 
 -casein: 5 phosphate groups 
 and -casein: 1-2 phosphate groups. 
The two most studied CPPs originate from s1- and -casein. Both of these CPPs (s1-
casein f(59-79)5P and -casein f(1-25)4P) contain a specific sequence known as the 
“acidic motif”. The “acidic motif” consists of 3 serine phosphate groups followed by 
two glutamic acid residues (Figure 1). At neutral pH, the “acidic motif” is a highly 
charged region and this has been linked with the ability of CPPs to bind minerals (Ca
2+
, 
Zn
2+
, Fe
2+
, Mn
2+
, Se
2+
, etc.) [Rose, 2000]. Seryl-phosphate groups are the main binding 
sites for calcium [Kitts, 2006]. Nevertheless, characterisation of the calcium binding 
constants to CPPs suggest that carboxylate groups may also be involved in calcium 
binding [Mekmene and Gaucheron, 2011]. Other CPP fragments such as s2-casein f(1-
21)4P and s2-casein f(46-70)4P have also been described in the binding of calcium 
[Cochrane et al., 2010; Cross et al., 2006; Kitts, 2006; Reynolds, 1998]. These 
phosphorylated peptide sequences can be released following hydrolysis of casein 
substrates with enzymes such as trypsin [Reynolds et al., 1995; Rose, 2000]. The high 
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charge content of CPPs which allows them to bind bivalent cations forming soluble 
complexes also appears to make them resistant to further hydrolysis [Silva and Malcata, 
2005; Vegarud et al., 2000]. 
2.2. Formation of CPPs 
CPPs are encrypted within the primary sequence of caseins and must be released in 
order to become active [FitzGerald, 1998].  
2.2.1. Release of CPPs from milk protein substrates 
A number of different release approaches exist as follows: 
 in vitro hydrolysis following incubation with proteolytic activities from 
mammalian, microbial and plant sources or via the utilisation of physical and/or 
chemical processes such as ultrasonic, microwave and chemical treatments. 
 hydrolysis by bacterial proteolytic/peptidolytic activities during the manufacture 
of fermented dairy products. Such hydrolysis may also occur in vivo following 
the action of intestinal microflora found in the human body. 
 in vivo digestion via the combined action of gastric and pancreatic hydrolases 
during gastrointestinal transit following oral ingestion. Subsequently, epithelial 
and serum peptidases may mediate further degradation assuming transport 
across the intestinal mucosa and transfer into the serum. Several studies 
performed in mammals including humans, pigs and rats have demonstrated the 
in vivo formation of CPPs following ingestion of milk and dairy products (Table 
1). CPPs have been found in the distal small intestine of rat, and in the stomach, 
duodenum and distal ileum of human subjects [Chabance et al., 1998; Hartmann 
and Meisel, 2007; Meisel et al., 2003] following the consumption of dairy 
ingredients and products. 
Most of the commercially available CPP preparations are released from casein using the 
first approach (i.e., enzymatic hydrolysis using proteolytic activities). Different 
pancreatic endoproteinases have been used to cleave casein substrates to release clusters 
of phosphorylated seryl residues [McDonagh and FitzGerald, 1998]. Amongst these 
enzymes, trypsin is the most commonly used [FitzGerald, 1998; Vegarud et al., 2000]. 
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Other enzymes from microbial and plant sources have also been used to release CPPs 
from sodium caseinate (NaCN) or other casein substrates [Adamson and Reynolds, 
1996; FitzGerald, 1998; Kitts, 2006; McDonagh and FitzGerald, 1998]. A general 
protocol for CPP production and isolation from sodium caseinate (NaCN) is presented 
on Figure 2 [Reynolds, 1991]. After tryptic hydrolysis of the NaCN substrate, the pH is 
adjusted to isoelectric pH of casein to precipitate unhydrolysed caseins [Reynolds et al., 
1994]. CPPs remain in solution and can be separated from the precipitated caseins using 
a centrifugation step. A calcium salt (BaCl2 or CaCl2) is added to the supernatant to 
form Ca
2+
 complexes with the phosphorylated peptides. At pH 3.5 combination of 
calcium and ethanol allows selective precipitation of the CPP sequences with the acidic 
motif [Reynolds et al., 1994]. Following this step, different pH adjustments are carried 
out to precipitate or resolubilise CPPs in order to separate them from other casein-
derived peptides. Sulphuric acid is then used to precipitate BaSO4 or CaSO4. After a 
centrifugation step, a supernatant containing CPPs is obtained and can be dialysed for 
further purification. Spray-drying of this product allows the obtension of a stable 
powder. 
2.2.2. Stability of CPPs during enzymatic hydrolysis process 
CPPs are formed and may be degraded during enzymatic hydrolysis. When performing 
casein hydrolysis with porcine Pancreatin
TM
, the formation of CPPs containing the 
“acidic motif” (Ser(P)-Ser(P)-Ser(P)-Glu-Glu) in the early stages of hydrolysis has been 
demonstrated (i.e., 10 min hydrolysis). However, these CPPs were totally degraded after 
6 h hydrolysis. Su et al. [2007] proposed a kinetic approach for casein hydrolysis in 
order to optimise the yield of CPPs. After one hour hydrolysis of casein with porcine 
Pancreatin
TM
, 27% of the CPPs identified contained the binding site for bivalent cations, 
i.e. Ser(P)-Ser(P)-Ser(P)-Glu-Glu [Su et al., 2007]. The optimum degree of hydrolysis 
(DH) may differ depending on the CPP sequence of interest. For example, s2-casein 
f(1-44)4P and s2-casein f(1-44)5P had a maximum yield at a DH of 3%, for s2-casein 
f(44-81)4P the optimum DH was 6% while for s2-casein f(46-80)4P the maximum 
yield was reached at a DH of 12% [Su et al., 2007]. 
The stability of CPPs following heat treatment at different pH values has been studied 
[Zhu and FitzGerald, 2010]. A heat treatment is generally applied following enzymatic 
hydrolysis of casein to heat inactivate the enzyme. The effect of the heat treatment (75 
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C, 45 min) at different pH values (6.0, 7.0 and 8.0) on the stability of CPPs has been 
studied. Mass spectrometric analysis of the trypsin hydrolysates (3h hydrolysis of 
sodium caseinate with tosyl phenylalanyl chloromethyl ketone (TPCK)-treated trypsin) 
subjected to the different heat treatments revealed some modifications in the CPP 
sequences. Differences between the heat-treated and the non-heat-treated hydrolysates, 
mainly came from dephosphorylation and oxidation of the CPP sequences identified. 
Heat treatment at pH 7.0 gave the highest number of CPPs with phosphorylated 
sequences. Additionally, the sequences identified following heat–treatment at pH 7.0 
were more similar to those identified in the non-heat-treated hydrolysate [Zhu and 
FitzGerald, 2010]. These results suggest that the heat-inactivation parameters employed 
post hydrolysis of casein play an important role in the stability of CPPs and will 
therefore affect bioactivity of the product obtained. 
 
2.2.3. Formation of caseinophosphopeptide-amorphous calcium phosphate (CPP-ACP) 
CPPs may act at different sites in vivo (Figure 3). Following ingestion, their first target 
is in the mouth where they may play a role in the repair of teeth lesions. Amorphous 
calcium phosphate (ACP- Ca3(PO4).3H2O) is the precursor of hydroxyapatite 
(Ca10(PO4)6(OH)2). In the presence of water, ACP can be converted into hydroxyapatite 
[Boskey and Posner, 1973]. At the tooth surface, calcium and phosphate precipitate in 
the stable format of hydroxyapatite [Skrtic et al., 2003]. Combinations of CPP and ACP 
have been utilised for remineralisation of the enamel surface and for reducing the rate of 
enamel decalcification. CPPs in tryptic digests having the acidic motif have been 
reported to stabilize amorphous calcium phosphate and to exhibit anticariogenic 
properties [Adamson and Reynolds, 1996; Kitts, 2006; Meisel et al., 2003]. CPP-ACP 
formation has been described [Walsh, 2009] where CPPs are aggregated with calcium 
phosphate and then purified by ultrafiltration, the nano-complexes are formed at a pH 
range between 5.0-9.0. The amount of calcium phosphate bound to the CPP increases 
with pH until an equivalent weight of calcium phosphate is bound to the CPP [Cross et 
al., 2007a; Walsh, 2009]. The protocol for the manufacture of CPP-ACP and CPP- 
amorphous calcium fluoro phosphate (ACFP) complexes has been described in the 
patents filed by Reynolds [2008c, 2011] (Figure 4). In this process CaCl2 was slowly 
added to the CPPs. An NaOH solution was then added to the previous mixture 
following each addition of CaCl2 to set the pH between values ranging from 7.0 to 5.0. 
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Then an Na2HPO4  solution was slowly added to form CPP-ACP complexes. For the 
manufacture of CPP-ACFP complexes, an extra step consisted of the incorporation of 
NaF. The CPP-ACP and CPP-ACFP complexes formed were soluble in water and 
therefore, they could be separated from the other components (other casein-derived 
peptides and salts) on a molecular weight basis. Slight variations to the previous 
protocol have been described for the preparation of CPP-ACFP complexes, where the 
pH was regulated to 9.0 and the microfiltration step was replaced by dialysis through a 
1 kDa membrane [Cross et al., 2004]. CPP-ACP complexes have been reported to be 
composed of a maximum of 6 peptide chains with a unit formula depending on the 
peptide involved: [s1-CN(59-79) (ACP)7]6 and [-CN(1-25) (ACP)8]6 [Cross et al., 
2007a]. The average hydrodynamic radii of the [-CN(1-25) (ACP)8]6 complex has 
been estimated using structural analyses (
1
H NMR) as 1.526±0.44 nm at pH 6.0 and 
1.923±0.082 nm at pH 9.0, respectively [Cross et al., 2007a]. Clusters of s1-casein 
f(59-79)-ACFP are reported to have a radius of about 2.12 nm [Cross et al., 2004]. 
These clusters are smaller than the CaF2 clusters which were developed as anticaries 
agents using two liquid nozzle spray-drying technology. These clusters had an estimated 
average diameter of 41 nm [Sun and Chow, 2008]. 
Teeth are composed of four tissues which from the outer to the inner compartment 
consist of enamel, dentin, cementum and the pulp respectively. The enamel and dentin 
are the sites of primary dental caries [Borges et al., 2011]. Therefore, these two tissues 
are sites for teeth remineralisation by CPP-ACP. In the oral cavity, CPP-ACP can act on 
the teeth at different levels as follows: 
 The enamel and dentin: where binding of ACP to the hydroxyapatite occurs. 
 The plaque: CPP-ACP can diffuse into dental plaque and display a buffering 
capacity which counteracts the pH drop caused by acidogenic bacteria 
[Adamson and Reynolds, 1996; Chen and Wang, 2010]. An additional role of 
CPP-ACP relates to an increase in calcium content in the plaque which results in 
a greater remineralisation of teeth lesions. CPPs have also been reported to 
localise ACP in dental plaque and prevent enamel from demineralisation 
[Adamson and Reynolds, 1996]. 
 12 
 
2.3. Commercial applications of CPPs 
Numerous patents concerning the manufacture of CPPs have been developed. Most 
applications relate to bovine milk as a source of CPPs (Table 2). A wide variety of 
starting substrates have been used, these vary from whole milk to other substrates with 
higher protein contents such as sodium caseinate. The patent literature describes similar 
strategies as those outlined in the scientific literature to release CPPs from milk protein 
substrates [FitzGerald, 1998]. Enzymatic hydrolysis appears to be the most frequently 
used technique to release CPPs, with a predominance of pancreatic activities such as 
trypsin being described in various patents. Mention of activities originating from plants 
such as papain (plant proteinase preparation extracted from papaya) is also made in two 
of the patents (Table 2). 
As CPPs represent approximately 10% (w/w) of the caseinate substrate [Reynolds, 
1998], most of the patenting activity has been carried out in the development of 
extraction techniques for CPPs from dairy protein hydrolysates. Such patents account 
for almost half of all the specifications described in Table 2. A large number of these 
patents deal with the selective extraction of CPPs using a combination of membrane 
separation, namely ultrafiltration (UF) employing a range of molecular weight cut-off 
(MWCO) membranes. CPP aggregation with bivalent salts or disaggregation by 
acidification or calcium sequestrants allow targeted size alteration in order to separate 
CPP from the non-phosphorylated peptides present in the hydrolysates using UF [Brule 
et al., 1982, 1985, 1989, 1991, 1993b, 1994b]. Other extraction techniques use ion-
exchange chromatography [Lihme et al., 1998]. An extraction protocol based on 
crosslinking of CPPs to chitosan beads has also been described [Koide et al., 1994]. In 
addition, the formation of chitosan-CPPs nanocomplexes mainly involving electrostatic 
interactions has recently been described in a research paper by Hu et al. [2011]. Many 
of the patents are relatively similar and are based on modifications of the sequence of 
steps involved in the extraction protocol, namely, modification of the size of CPPs 
aggregates at different stages of the extraction procedure. 
One third of the patents have been targeted at oral hygiene applications as CPPs have 
been associated with the regression of dental caries, anti-calculus and desensitizing 
properties at the teeth level. Additionally, the development of new formulations or the 
discovery of new CPP sequences has been addressed in these patents. The application of 
CPPs in different formats either as a means to increase the solubility of minerals in 
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beverages [Naito et al., 1995] or in the formation of clusters with high calcium contents 
[Holt, 2006] have been described. The manufacture of a sterile pharmaceutical 
composition for the management of lactating livestock animals has also been outlined 
[Iscovich et al., 2011]. The discovery of novel CPP sequences has been addressed in 
two patents [Han and Shin, 2001b; Han and Shin, 2001a]. 
A Generally Recognised As Safe (GRAS) status has been attributed to CPPs by the 
Food and Drug Administration (FDA) and other regulatory bodies for their use in foods 
and oral care products [Cochrane et al., 2010]. An evaluation of the cytotoxicity of 
CPP-ACP paste has been carried out in vitro using rat fibroblasts [Bussadori et al., 
2010] where the cells were covered with round cover slips coated with CPP-ACP. The 
study concluded that there was a low cytotoxicity for CPP-ACP paste, with a slight 
decrease in cell viability (80-90% cell viability after 4 h exposure to a CPP-ACP paste). 
Nevertheless, cell viability was above 70 % after longer exposure periods (i.e., 7 days). 
As CPP-ACP was only used topically, this level of toxicity was considered acceptable. 
Therefore, CPP-ACP was classified as safe for use in topical applications for dentistry 
[Bussadori et al., 2010]. A wide range of CPP ingredients and CPP containing products 
are currently available in the marketplace [Phelan et al., 2009] (Table 3). These CPPs 
originate from the different bovine caseins. Most commercial products containing CPPs 
are found in the oral hygiene sector in the format of pastes, dental creams and chewing 
gums. The other commercial applications of CPPs are in the format of soft drinks or 
dairy foods (Table 3). 
In summary, CPP sequences have been well characterised. The formation of CPPs 
naturally occurs in vivo during gastrointestinal digestion. At a commercial level, CPPs 
are mainly produced by the action of hydrolytic enzymes (pancreatic activities) on 
bovine milk protein substrates. CPPs have GRAS status and are commercially available 
in the market place in the format of ingredients, oral hygiene and food products. Many 
patents have been filed in relation to CPPs. These mostly describe extraction techniques 
of CPPs from milk protein hydrolysates, followed by new oral hygiene products, food 
and animal feed formulations and finally the discovery of new CPP sequences. 
3. General mechanisms of action of CPPs in the oral cavity 
Carious lesions can be naturally repaired by remineralisation [Chen and Wang, 2010]. 
Remineralisation is defined as a restoration of lost dental apatite [Cross et al., 2006]. 
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However, this remineralisation process is not always sufficient to repair lesions, as 
demineralisation and remineralisation are cyclical events [Lussi, 2009; Peters, 2010] 
and a disruption in the overall balance of both processes can be detrimental to tooth 
repair (i.e., when demineralisation occurs at a faster rate than remineralisation) [Hamba 
et al., 2011; Pradeep and Prasans, 2011; Walker et al., 2010]. Therefore, lesions need to 
be repaired using different strategies that favour remineralisation [Chen and Wang, 
2010; Peters, 2010]. If the lesions are detected at an early stage, they can be reversed 
with a non-invasive procedure to avoid caries development [Elsayad et al., 2009; Peters, 
2010]. To be considered as an efficient remineralising agent, a product has to increase 
remineralisation, decrease demineralisation and be retained on the enamel surface in 
order to display activity [White, 1995]. This must be achieved before the next acid 
challenge [Borges et al., 2011]. The basic requirements for remineralisation agents 
include the following [Borges et al., 2011; Pitts and Wefel, 2009; Zero, 2009]. 
  be safe for human use and display an effective bioactivity 
  display rapid precipitation on partially demineralised teeth 
  transform into a stable apatite resistant to subsequent attack by bacteria and 
other erosion agents 
  display a beneficial action over fluoride 
  be more efficient than the demineralisation that naturally occurs following 
saliva erosion 
 be active both at the surface and the subsurface of the lesion, and have the 
ability to diffuse through the biofilm and into the lesion subsurface. 
 
3.1. Role of fluorides in the prevention of dental caries and erosion  
Different agents have been used to prevent caries and improve remineralisation of the 
enamel. Amongst these, fluoride has been widely used to prevent caries and dental 
erosion. Fluoride can precipitate at the enamel subsurface in the form of calcium 
fluoride (CaF2) or fluoroapatite (Ca10(PO4)6F2) and protect dental enamel from erosion 
during abrasive brushing and demineralisation [Lussi, 2009; Reynolds, 2009; ten Cate, 
1999]. Fluoroapatite crystals have been reported to be relatively insoluble, allowing 
them to protect the enamel from further demineralisation [Peters, 2010]. Fluoride is the 
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most widely used and the most efficient agent to aid remineralisation and prevent 
demineralisation of teeth, making it the reference agent against which new 
remineralisation agents are compared [Pfarrer and Karlinsey, 2009]. Nevertheless, the 
concentrations of fluoride utilized in over-the-counter toothpastes (around 1000 ppm 
fluoride) may not be sufficient. Indeed, White [1995] reported that most over-the-
counter toothpastes and mouth rinses did not contain sufficient fluoride to significantly 
react with sound enamel. Additionally, Lussi [2009] noted that there has been an 
increase in dental erosion even though most toothpastes are fluorinated. It appears that 
on its own and at dosages commonly used in commercial dental hygiene products, 
fluoride is not sufficient to completely prevent the development of dental caries [Rao et 
al., 2009]. 
Hydroxyl groups from hydroxyapatite can be replaced by fluoride yielding fluoroapatite 
(Ca5(PO4)3F), which is more resistant to acid erosion [Ostrom et al., 1984]. A relatively 
large amount of calcium is required to form fluoroapatite (10 calcium to 2 fluoride 
ions), suggesting that calcium availability could be a limiting factor in the formation of 
fluoroapatite and more generally in enamel remineralisation [Cross et al., 2007b; 
Reynolds, 2009; Walsh, 2009]. Furthermore, Reynolds et al. [2008] demonstrated in an 
in situ experiment that the availability of calcium and phosphate ions could be a limiting 
factor in the formation of hydroxyapatite.  
 
3.2. Remineralisation properties of CPPs 
The combination of fluoride with a source of bioavailable calcium as an adjunct has 
been proposed for the treatment of early stage caries [Cross et al., 2006; Peters, 2010; 
Reynolds, 2009]. Indeed, the incorporation of CPP-ACP in a toothpaste with 1100 ppm 
fluoride resulted in higher remineralisation than when fluoride was used on its own 
[Reynolds et al., 2008]. The utilisation of calcium phosphate on its own or per se has 
not been successful in increasing remineralisation of the tooth surface, mainly due to the 
low solubility of these ions especially in the presence of fluoride [Azarpazhooh and 
Limeback, 2008; Reynolds, 2009]. This low solubility results in an inefficient 
attachment to the tooth surface [Reynolds, 2008b]. Unhydrolysed caseins can have 
anticariogenic properties [Rodrigues et al., 2011], however these effects are only seen at 
relatively high doses [Aimutis, 2004; Cross et al., 2006, 2007b]. An in vivo study has 
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been conducted supplementing caseins in the diet of rats infected with cariogenic 
Streptococcus sobrinus and plaque forming Actinomyces viscosus [Guggenheim et al., 
1999]. The results of this study clearly demonstrated the anti-cariogenic and anti-plaque 
effect of caseins. Nevertheless, on a weight basis, the dose required to observe an 
anticariogenic effect was reported to be at least 10 times more for casein than for CPPs 
[Azarpazhooh and Limeback, 2008; Cross et al., 2006; Gupta and Prakash, 2011; 
Moezizadeh and Moayedi, 2009; Reynolds, 1998]. CPPs are therefore attractive for 
their anticariogenic action and their potency as compared to their original milk protein 
substrate. The positive role of CPPs on the enhancement of calcium and phosphate 
solubility and their stabilisation at the tooth surface has therefore been exploited as a 
non-invasive procedure to prevent teeth demineralisation [Cochrane et al., 2010]. CPPs 
promote enamel remineralisation of carious lesions by maintaining a supersaturated 
state of calcium at the enamel surface. CPPs have a relatively low dissociation constant 
for calcium phosphate, i.e. of the order of several mM, which may be responsible for an 
increased bioavailability of calcium phosphate [Cochrane et al., 2010]. They also act as 
buffering agents, preventing a pH decrease in the oral cavity [Rahiotis et al., 2008], the 
saliva and plaque [Kitasako et al., 2010]. This buffering capacity helps prevent the 
dissolution of hydroxyapatite from the enamel. Cross et al. [2007a] described the two 
main roles of CPPs as being a stabilisation of calcium phosphate in solution to prevent 
precipitation and crystal growth and a biomineralisation action with crystal growth 
promoter properties at the tooth surface. 
During in situ remineralisation experiments, Reynolds et al. [2003] demonstrated the 
positive role of CPP in stabilising ACP and delivering soluble calcium and phosphate to 
the enamel surface. The remineralisation obtained with sugar-free chewing gums 
containing CPP-ACP was two times higher than that obtained with chewing gums with 
CaHPO4/CO3 or CaCO3. This was despite the fact that the amounts of calcium were 8-
13 times lower in the CPP-ACP chewing gum. This demonstrates the higher efficacy of 
CPP-ACP to deliver calcium phosphate at the enamel surface for optimum 
remineralisation [Reynolds et al., 2003]. Additionally, enamel remineralised following 
CPP-ACP delivery is more acid resistant than normal enamel, making it more stable in 
respect to further acid challenge [Iijima et al., 2004; Reynolds, 2008b]. CPP-ACP was 
also shown to remineralise the interior of the lesions whereas fluoride products only 
remineralise lesion surfaces [Shen et al., 2011]. In addition to their remineralising 
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properties, CPP-ACP can bind to dental plaque [Azarpazhooh and Limeback, 2008; 
Rose, 2000]. In this respect, the action of CPP-ACP is very similar to that reported for 
fluoride, i.e., inhibition of demineralization, enhancement of remineralisation and 
inhibition of bacterial enzymes [Walsh, 2009]. 
 
3.3. Vehicles of CPP-ACP for use in the oral cavity 
Different strategies involving CPP-ACP have been proposed in order to restore minerals 
that have been lost during the erosion process. These include [Gupta and Prakash, 
2011]: 
 Direct oral hygiene route via the utilisation of topical gels [Elsayad et al., 2009; 
Kumar et al., 2008; Rehder Neto et al., 2009; Reynolds, 1999, 2008b], or mouth 
rinses [Reynolds et al., 2008; Reynolds et al., 2003] containing remineralising 
agents.  
 Adjuncts for oral hygiene using other vehicles for CPP-ACP delivery such as 
chewing gum [Reynolds et al., 2003; Shen et al., 2001] and lozenges [Cai et al., 
2003]. Sugar-free sorbitol or xylitol based chewing gums are being the most 
commonly tested vehicles for the application of CPP-ACP in human oral 
environment [Yengopal and Mikenautsch, 2009]. 
 Foods: dairy foods and especially cheese is known as a good source of minerals. 
Dairy products including milk supplemented with CPP-ACP [Walker et al., 
2006; Walker et al., 2009] and yoghurt supernatants [Ferrazzano et al., 2008], 
have been employed to deliver minerals to the tooth surface. Other vehicles such 
as confectionaries [Walker et al., 2010] and soft drinks [Manton et al., 2010] 
have also been described. 
Different commercial products enriched in calcium phosphate are available on the 
market for the remineralisation of tooth surface (Table 4): these include Enamelon
TM
, 
Novamin
TM
 and Recaldent
TM
 [Azarpazhooh and Limeback, 2008; Reynolds, 2008b]. 
Enamelon
TM
 and Novamin
TM
 are respectively composed of amorphous calcium 
phosphate and a bioactive glass of calcium sodium phosphosilicate [Azarpazhooh and 
Limeback, 2008; Rehder Neto et al., 2009; Reynolds, 2008b]. Recaldent
TM
 is a stable 
and highly soluble CPP complex loaded with calcium, phosphate and hydroxide ions 
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[Cross et al., 2007b]. CPPs can bind calcium via their phosphate residues, resulting in 
the formation of CPP-ACP nanoclusters with a radius about 1.5 nm [Reynolds, 2009]. 
These nanoclusters prevent nucleation and precipitation and increase calcium phosphate 
solubility [Azarpazhooh and Limeback, 2008; Reynolds, 1998; Rose, 2000]. An 
increase in calcium (6.5 times) and phosphate (7.9 times) concentration in saliva 
following utilisation of a paste containing Recaldent
TM
 compared to a placebo product 
has been reported [Shen et al., 2011]. Recaldent
TM
 carries more calcium, phosphate and 
hydroxide ions in comparison to open CPP-ACP complexes, therefore, it has been 
reported to be a more efficient anticariogenic agent [Cross et al., 2007b]. It has also 
been described as being less bitter and having a lower allergenic potential when 
compared to casein [Rodrigues et al., 2011]. Recaldent
TM
 contains bovine milk derived 
CPPs (with the sequence -Ser(P)-Ser(P)-Ser(P)-Glu-Glu stabilising nanoclusters of ACP 
in metastable solution) [Cross et al., 2007b; Shen et al., 2001; Walsh, 2009] and is used 
in products such as Trident white sugar gum, Recaldent
TM
 sugar free gum, Recaldent 
mints
TM
 and MI Paste (Tooth mousse) [Azarpazhooh and Limeback, 2008; Gupta and 
Prakash, 2011] (Table 3). The CPP composition of Recaldent
TM
 has been characterised 
and it is mainly composed of s1-casein f(59-79)5P, -casein f(1-25)4P, s2-casein f(46-
70)4P and s2-casein f(1-21)4P [Cross et al., 2007a; Reynolds, 2008c]. Under alkaline 
conditions (pH 7 to 9), s1-casein f(59-79) and -casein f(1-25), can bind a maximum of 
21 and 24 Ca and 14 and 16 Pi, respectively [Cross et al., 2007a]. 
 
In summary, the natural repair of carious lesions in the oral cavity can be improved by 
supplementation with different compounds improving teeth remineralisation. These 
include the utilisation of remineralising agents such as fluoride, the reference agent for 
teeth remineralisation. The formulation of most over-the-counter toothpaste may not 
include sufficient amounts of fluoride for optimum remineralisation of teeth lesions. 
Combinations of fluoride and CPP-ACP as a source of bioavailable calcium have been 
successfully utilised to enhance remineralisation of teeth. CPP-ACP has been used in 
the formulation of oral hygiene products, as adjuncts for the oral hygiene and as food 
products. Owing to their low calcium and phosphate dissociation constants, their ability 
to stabilise calcium phosphate into solution and to prevent its early precipitation, CPPs 
display their remineralising properties allowing crystal growth at the teeth surface. 
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4. Methodology to assess teeth remineralisation properties of CPPs 
A large number of studies have been conducted using different vehicles to assess 
remineralisation of enamel or dentin. From a methodology viewpoint, artificial lesion 
approaches have been extensively used to study caries as they show the same 
histological features as in natural caries and are easier to reproduce, making them highly 
suitable as a model to study remineralisation of enamel lesions [Kumar et al., 2008]. 
Single section lesions are sections of natural lesions [White, 1995], their utilisation 
allows accurate measurement of mineral changes within the lesions [Itthagarun et al., 
2005; White, 1995]. The plaque formed in enamel sections is similar to the natural 
plaque from a microbiological and biochemical point of view [Itthagarun et al., 2005]. 
When in situ studies are used as a prediction tool for subsequent in vivo human 
intervention trials, this allows a better control for product-unrelated variables [ten Cate, 
1999]. The lesions can be studied both with human and bovine teeth. Bovine teeth are a 
good model as they have been reported to be similar to human teeth in terms of physical 
and compositional characteristics [Wegehaupt et al., 2011; Wu et al., 2010]. Bovine 
teeth are easier to obtain than human teeth and can be sourced from the same 
geographical area, reducing inter-variability that can be caused by environmental and 
nutritional factors [Wegehaupt and Attin, 2010]. Additionally, they are normally not in 
contact with fluorides and do not present caries [Wegehaupt and Attin, 2010]. 
Furthermore, bovine incisors present a larger surface area than human teeth allowing the 
preparation of more than one sample per tooth, which can help minimise intertooth 
differences [Wegehaupt and Attin, 2010]. 
Differences between protocols to measure remineralisation and demineralisation 
generally come from the substrate used to conduct the experiment. Remineralisation 
experiments are generally carried out on lesions whereas demineralisation protocols use 
a larger range of options including teeth that have been pre-treated by remineralising 
agents or natural enamel or teeth with surface lesions [White, 1995]. Remineralisation 
models in vitro have been classified into three categories as follows: the pH-lattice ion 
drift method which consists of exposing the tooth surface to a remineralising solution of 
constant volume that is supersaturated with remineralising agents. The pH and 
concentration of the remineralising agents are not regulated in this case and therefore 
are subject to changes over the time course of the experiment. The second model is a 
flow-through technique to the teeth surface; the remineralising solution is 
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supersaturated and has a large volume to ensure a constant thermodynamic driving force 
during remineralisation. The third model or titration-controlled composition procedure 
consists of constantly adding the remineralising agent in the remineralising solution 
[White, 1995]. Some in vitro protocols are classified as pH cycling; they consist of 
exposing the teeth to cycles of demineralisation and remineralisation. These protocols 
aim to reproduce the natural caries process while simulating changes in mineral 
saturation and pH that occur when subjects have plaque and consume carbohydrates at 
regular intervals [ten Cate, 1999]. 
In situ protocols are quite similar to in vitro protocols regarding the methodologies used 
to assess remineralisation and demineralisation of tooth surfaces. Studies carried out in 
situ utilise removable intra-oral appliances holding enamel slabs which previously went 
through a demineralisation protocol [ten Cate, 1999]. The demineralisation protocol can 
lead to the formation of subsurface lesions of 80-110 m in depth [Azarpazhooh and 
Limeback, 2008]. Appliances can be worn by human subjects for a given period of time 
when the anticariogenic protocol is applied. They are then removed and the enamel 
slabs are analysed with different analytical techniques such as microradiography to 
study remineralisation of the enamel subsurface, the depth of the lesions, etc., and 
densitometric analysis to monitor changes in mineral content [Azarpazhooh and 
Limeback, 2008; Reynolds, 1997a]. More recently, non-destructive methods utilising in 
situ laser autofluorescence spectroscopy [Elsayad et al., 2009] and in vitro micro-
computed tomography [Hamba et al., 2011] have been developed to study the 
remineralising potential of CPP-ACPs. 
A very large number of studies have been carried out to assess the efficacy of CPP-ACP 
to remineralise tooth surface using in vitro and mainly in situ methodologies [Rodrigues 
et al., 2011]. At present the number of in vivo studies carried out is limited but an 
increase in the number of human intervention trials reported in the literature is 
beginning to occur (Table 5). The aim of these studies has been to assess the impact of 
CPP-ACP on the regression of dental caries and plaque [Caruana et al., 2009; Morgan et 
al., 2008; Reynolds et al., 2008; Reynolds et al., 2003] or on the regression of white 
spot lesions (WSL) which may appear following the use of intra-oral appliances 
[Andersson et al., 2007; Bailey et al., 2009; Beerens et al., 2010; Brochner et al., 2011; 
Kitasako et al., 2010]. 
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5. Determination of the role of CPP-ACP on teeth remineralisation and 
prevention of demineralisation in vitro and in situ 
The maintenance of a target mineral concentration for healthy teeth is conditioned by 
the balance between demineralisation and remineralisation of the enamel. Most research 
on the action of CPPs in the mouth has been carried out with in vitro and in situ 
protocols employing a wide range of vehicles ranging from oral hygiene products 
(topical gels and mouthwashes) to adjuncts for oral hygiene (gums, lozenges) or foods 
(milk, yoghurt, sweets, soft drinks, etc.) [Gupta and Prakash, 2011]. 
5.1. CPP-ACP action during oral hygiene protocols 
5.1.1. Remineralisation potential of CPP-ACP on carious lesions 
CPP-ACP has been applied in paste format in vitro to the enamel and dentin of bovine 
teeth that were previously subjected to demineralisation with a 0.1M lactic acid buffer 
solution. The use of CPP-ACP resulted in an increase in the remineralisation of the 
dental enamel and dentin [Reynolds et al., 1999] as observed microscopically (Field 
Emission- Scanning Electron Microscopy - FE-SEM). Similar results were obtained in 
vitro with primary human teeth (6 year old lower incisors), showing higher 
remineralisation of enamel lesions with CPP-ACP compared to a 500 ppm NaF solution 
[Zhang et al., 2011]. This study [Zhang et al., 2011] was designed to address early 
childhood caries and concluded that there was a positive effect of CPP-ACP on early 
enamel lesions of primary teeth. The observed suppression of demineralisation and 
enhancement of remineralisation of tooth surfaces in the presence of CPP-ACP has been 
explained by a positive effect of CPP via the localisation of the ACP on the tooth 
surface. CPP-ACP is thought to prevent demineralisation and enhance remineralisation 
by increasing the concentration of calcium and phosphate ions, leading to a state of 
supersaturation [Reynolds et al., 1999]. 
CPP-ACP has been used to combat demineralisation during orthodontic treatment. The 
utilisation of fixed orthodontic appliances can often result in the accumulation of dental 
plaque and demineralisation around the brackets [Andersson et al., 2007; Bailey et al., 
2009; Beerens et al., 2010; Peters, 2010; Sudjalim et al., 2006; Xiaojun et al., 2009]. As 
a consequence, the prevalence of demineralisation is higher with people wearing 
appliances as compared to people without orthodontic treatment [Beerens et al., 2010; 
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Sudjalim et al., 2006; Wu et al., 2010]. This can cause the appearance of white spot 
lesions (WSL) at the tooth surface that can further develop into caries [Beerens et al., 
2010; Sudjalim et al., 2006; Uysal et al., 2010]. WSL development have been associated 
with inadequate hygiene and with plaque build-up in areas that are difficult to access 
during cleaning procedures or natural self-cleansing mechanisms such as oral 
musculature and saliva movement [Sudjalim et al., 2006]. Recently, the secondary 
treatments to prevent WSL and to improve their appearance after debonding have been 
reviewed by Bergstrand and Twetman [2011]. Bovine enamels were treated with Tooth 
Mousse and enamel remineralisation was assessed employing polarised digital imagery 
[Wu et al., 2010]. Most studies to assess remineralisation of dental enamel have been 
carried out with macroscopic methods, clinical examination and quantitative light 
induced fluorescence, but a restricted number of studies utilised polarised digital 
images. Polarised filters avoid reflections coming from the flash in digital photography, 
these reflections can cause an overestimation of the actual WSL at the tooth surface 
[Wu et al., 2010]. The advantage of circular polarised lens over linear polarised lens is 
that it gives a clearer image of the actual demineralised areas [Wu et al., 2010]. The 
application of Tooth Mousse resulted in a reduction in the demineralised areas and this 
effect was more pronounced when CPP-ACP was combined with fluoride toothpaste. 
 
Synergistic effects of CPP-ACP and fluoride have been reported in several studies 
[Kumar et al., 2008; Reynolds, 2008b; Shen et al., 2011]. When CPP-ACP (Tooth 
Mousse) was used as a topical coating following treatment with fluorinated toothpaste, 
the reduction of lesions was of the order of 13.1%. (in comparison to 7.0% for the 
fluorinated toothpaste alone and 10.1% for the CPP-ACP paste) [Kumar et al., 2008]. 
This result suggests that a combination of fluoride and CPP-ACP can help to improve 
the appearance of enamel lesions. Fluoride is important at plaque level as it is involved 
in the formation of fluoroapatite and can therefore promote remineralisation of the 
enamel subsurface [ten Cate, 1999; Walsh, 2009]. There may be some incompatibility 
issues between fluoride and CPP-ACP. In formulations containing the two substances, 
the availability of fluoride can decrease [Pfarrer and Karlinsey, 2009]. A practical 
solution to this issue includes physical separation with the use of a dual chamber 
packaging, formulation changes to minimise interactions between fluoride and CPP-
ACP or the reduction of water content [Pfarrer and Karlinsey, 2009]. Nevertheless, it 
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was reported that in a product such as MI Paste, ACP should not interact with fluoride, 
and precipitate as CaF, due to the relatively low fluoride concentration (900 ppm) 
[Gupta and Prakash, 2011]. When a fluoride mouth rinse was supplemented with 2% 
CPP-ACP the incorporation of fluoride in the plaque was shown to increase by a factor 
of more than two [Reynolds et al., 2008] in an in situ experiment. Additionally, 2% 
CPP-ACP gave higher remineralisation with and without acid challenge than a 2800 
ppm fluoride toothpaste. The 2% CPP-ACP toothpaste also gave higher remineralisation 
results than the 1100 ppm fluoride paste [Reynolds et al., 2008]. The combination of 
Tooth Mousse Plus (containing 900 ppm fluoride) [Walsh, 2009] and the oral mouth 
wash Relief ACP containing fluoride was studied using a non-destructive optical 
method based on laser autofluorescence spectroscopy to monitor lesion 
development/resorption [Elsayad et al., 2009]. A synergistic effect of fluoride and CPP-
ACP was demonstrated. Remineralisation following utilisation of both products resulted 
in superimposed spectra for the sound enamel subsurface and the remineralised 
subsurface. When GC Tooth Mousse was used on its own, a shift from 540 (sound 
enamel) to 500 nm (remineralised enamel) for the peak maximum was seen. Similarly, 
Shen et al. [2011] reported a synergy between CPP-ACP and fluoride with a 3.7 fold 
increase in remineralisation level following the use of Tooth Mousse Plus as compared 
to a 1000 ppm fluoride toothpaste. Remineralisation of teeth specimens was shown to 
be higher with CPP-ACFP when compared to CPP-ACP [Jayarajan et al., 2011]. The 
use of CPP-ACFP was advised over fluoride as a slow delivery system for fluoride in 
the lesions. This gradual release allowing curing of the lesions as opposed to high 
fluoride concentrations, which result in hypersurface mineralisation, preventing repair 
of the lesion [Jayarajan et al., 2011]. The localisation of the ACFP was reported to 
increase the degree of saturation with respect to fluoroapatite [Cross et al., 2006]. CPP-
ACFP complexes possibly prevent rapid precipitation of fluoroapatite at the tooth 
surface, allowing a gradual release of calcium, phosphate and fluoride ions [Cross et al., 
2007b]. All three ions (fluoride, calcium and phosphate) were free to diffuse at the 
enamel subsurface [Reynolds, 2009]. An estimated diffusion coefficient of 3×10
-10 
m
2
.s
-
1 
for remineralisation has been reported [Cross et al., 2006; Reynolds, 1998]. 
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Contradictory results have been reported regarding the efficacy of toothpastes 
containing CPP-ACP. Rehder Neto et al. [2009] compared the effect of different oral 
pastes on bovine dental surfaces with induced caries-like lesions (pH cycling protocol). 
Remineralisation of the tooth surfaces was seen with the different remineralising agents 
tested (toothpaste with fluoride, MI paste, MI paste with fluoride and Tooth Revitalising 
Paste containing Novamin). Higher amounts of mineral changes on the enamel surfaces 
were obtained with the fluoride toothpaste and Tooth Revitalising Paste (7.2 and 6.7%, 
respectively). MI paste and MI paste with fluoride gave lower changes in mineral levels 
of 3.3 and 3.2%, respectively [Rehder Neto et al., 2009]. The pastes containing the 
CPP-ACP were effective in increasing remineralisation, nevertheless, higher 
remineralisation was achieved with fluoride and Novamin pastes. In another study, the 
micro-hardness of teeth was investigated. CPP-ACP paste and a fluoride toothpaste 
allowed remineralisation around an orthodontic bracket but in contrast to a previous 
study [Rehder Neto et al., 2009], no significant difference could be measured between 
CPP-ACP and fluoride [Uysal et al., 2010]. Additionally, the in vitro study conducted 
by Lata et al. [2010] did not demonstrate any benefit on the remineralisation of 
subsurface lesions while using CPP-ACP on its own or when applied in a fluoride 
varnish. In this study, the remineralisation of enamel was only seen at the surface level 
with both treatments (CPP-ACP alone and CPP-ACP applied in a fluoride varnish ) 
[Lata et al., 2010]. 
 
5.1.2. Protective effect of CPP-ACP during erosion 
In in vitro studies, Tooth Mousse was shown to be effective in reducing erosion of 
dentin in conditions involving heavy attrition (physical wear) against opposing enamel 
surfaces [Ranjitkar et al., 2009a]. Erosive wear of dentin and enamel was reduced 
following the application of Tooth Mousse after an in vitro simulation of dentin and 
enamel wear following toothbrush abrasion [Ranjitkar et al., 2009b]. It was 
demonstrated that four topical applications of CPP-ACP paste (Prospec
TM
, MI Paste) 
were effective in preventing dental erosion [Tantbirojn et al., 2008]. After contact with 
a cola beverage, treated teeth presented a harder enamel surface compared to untreated 
teeth [Tantbirojn et al., 2008]. These results are in agreement with another study which 
tested the effect of CPP-ACP on the micro hardness of enamel following erosion with a 
cola drink, where CPP-ACP treatment resulted in a 13% increase in tooth hardness 
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[Panisch and Poolthong, 2009]. Intermittent application of Tooth Mousse reduced 
dentin wear and continuous application resulted in a diminution of dentin wear rate 
[Panisch and Poolthong, 2009]. Similar results were obtained in vitro with white wine 
(White Riesling, pH 3.5) erosion of human teeth, where the application of Tooth 
Mousse resulted in reduction of the erosion depth both for enamel and dentin [Piekarz et 
al., 2008]. Tooth Mousse has been used in vitro to remineralise a tooth specimen 
following an erosion protocol with chlorinated water [Vongsawan et al., 2010]. The 
microhardness of the teeth was restored following application of Tooth mousse or the 
immersion of the teeth in a commercial high calcium milk (Anlene
TM
). This study 
demonstrated the remineralisation potential of CPP and high calcium milk following 
teeth erosion with chlorinated water [Vongsawan et al., 2010]. An in situ study 
conducted on the remineralisation potential of CPP-ACP after erosion with Coca Cola 
also showed the synergistic effect of fluoride and CPP-ACP [Srinivasan et al., 2010] 
where remineralisation increased from 46.2 (Tooth Mousse) to 64.25% (Tooth Mousse 
plus containing 900 ppm fluoride). The synergistic effect of CPP-ACP and fluoride has 
been attributed to the formation of a stabilised ACFP phase [Kumar et al., 2008; 
Moezizadeh and Moayedi, 2009; Reynolds, 2008b].   
 
In contrast, different studies showed no protective effect of CPP-ACP on erosion. 
Recently, Wegehaupt et al. [2011] conducted an in situ study where they evaluated the 
protective effect of CPP-ACP following erosion of bovine teeth with a soft drink (Sprite 
light). The baseline surface microhardness of the teeth could not be restored both when 
Tooth Mousse or fluoride mouth rinse were used following the erosive protocol. When 
CPP-ACP was applied to bovine enamel in vitro, no significant decrease in the 
reduction of abrasion (tooth brushing) / erosion (demineralisation with HCl) could be 
demonstrated [Wegehaupt and Attin, 2010]. These results suggest that there was no 
positive effect of CPP-ACP on the reduction of tooth wear [Wegehaupt and Attin, 
2010]. Nevertheless, in this study, the CPP-ACP mousse was applied only once a day as 
opposed to other studies where application could vary from continuous to several daily 
intermittent applications of Tooth Mousse [Ranjitkar et al., 2009a; Ranjitkar et al., 
2009b]. This observation raises the question of the frequency/duration of CPP-ACP 
application required to achieve a protective effect on dental abrasion and erosion. 
Similar results were found where the application of CPP-ACP on human teeth in vitro 
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did not improve surface nano-hardness [Wang et al., 2011]. This study was carried out 
with clinically relevant parameters with an acid challenge applied for 3 min with orange 
juice and an application time onto the tooth surface of 3 min for the CPP-ACP paste. No 
protective effect on erosion could be seen using Scanning Electron Microscopy (SEM) 
as CPP-ACP failed to form a continuous layer at the tooth surface and instead was 
deposited as scattered granules. The difference with other studies which concluded in a 
protective effect of CPP-ACP was attributed to the shorter application time used in this 
study. Furthermore, at the low pH of the orange juice (pH 3.6), CPP net charge is 
positive, reducing its affinity for the enamel, which may explain the results obtained 
[Wang et al., 2011]. In contrast, a study carried out in vitro with a similar application 
time of 3 min concluded in a protective effect of CPP-ACP on dental erosion of human 
teeth with an acid challenge (Cola, pH 2.44) [Poggio et al., 2009]. Structural changes 
were observed on tooth surfaces using Atomic Force Microscopy (AFM), with tooth 
cavity being more filled when CPP-ACP was used after the acid challenge as compared 
to no CPP-ACP application. Erosion cavity depth was reduced from 50 (no CPP-ACP 
application) to 20 m (CPP-ACP application), showing the protective effect of CPP-
ACP. These results contradict the findings of Wang et al. [2011] regarding pH and time 
exposure on the protective effect of CPP-ACP. The main difference between both 
studies may arise from the rinsing procedure of the teeth after application of the CPP-
ACP paste, a relatively harsh rinsing procedure (50 s under tap water followed by 10 s 
with deionised water and 5 s drying with oil-free air) was applied in the study of Wang 
et al. [2011]. The teeth were rinsed with deionised water in the study of Poggio et al. 
[2009]. The rinsing procedure could affect the efficiency of the active ingredient as it 
may act for longer if not fully rinsed off the teeth. For this reason it has been proposed 
not to vigorously rinse teeth after the utilisation of fluoride containing toothpastes on 
tooth brushing. Rinsing with a small amount of water [Rodrigues et al., 2011] and even 
a no-rinse procedure [Peters, 2010; ten Cate, 1999] has been advised in order to increase 
retention of the remineralising agent (fluoride) in the mouth. 
 
Other studies concluded that no synergy occurred between CPP-ACP and fluoride; for 
instance during the early stages of erosion caused by a cola beverage on the enamel 
subsurface of bovine teeth [Tantbirojn et al., 2008]. The level of fluoride used in the 
study was nevertheless relatively low: 1 ppm fluoride in artificial saliva as opposed to 
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several hundred ppm fluoride in previous studies showing synergistic effects between 
CPP-ACP and fluoride. Similarly, in the study of Wang et al. [2011], no additional 
protection of CPP-ACP in the presence of 900 ppm of fluoride could be observed. This 
study concluded that there was no protective effect of protective agents (CPP-ACP, 
CPP-ACFP or Novamin) on erosion caused by an acid challenge. 
5.2. Role of CPP-ACP in vitro and in situ during the use of adjuncts for oral 
hygiene: lozenges and chewing gums 
Lozenges and chewing gums are classified as adjuncts for oral hygiene that can be used 
in addition to the conventional teeth cleaning procedures. The advantage of using 
chewing gum as a carrier is that it has a longer residence time in the mouth as compared 
to toothpaste or mouthwash [Sanares et al., 2009]. Remineralising agents that are 
retained in the oral cavity are more efficient as they can act for longer at the tooth 
surface. Chewing gum additionally acts on increasing saliva flow, which has been 
positively associated with an increased protection of the teeth [Imfeld, 1999]. The 
importance of controlled release of anticaries agents in the oral cavity has been stressed 
in different review papers [Chen and Wang, 2010; Pitts and Wefel, 2009]. 
Addition of CPP-ACP in lozenges were shown to induce an increase in the 
remineralisation of subsurface enamel lesions by 78 and 176% when the amount of 
CPP-ACP was increased from 18.8 to 56.4 mg, respectively [Cai et al., 2003]. Similar 
results were obtained regarding the incorporation of CPP-ACP in sugar-free gums 
(Recaldent
TM
) with a 102 and 152% remineralisation increase with 18.8 to 56.4 mg 
CPP-ACP, respectively [Shen et al., 2001]. A larger range of CPP-ACP amounts were 
tested with sugar-free gums (0.19, 10, 18.8 and 56.4 mg) and the percentage of 
remineralisation of the enamel showed a dose-response pattern between CPP-ACP dose 
and remineralisation of the enamel subsurface [Shen et al., 2001]. 
Trident White
TM
 gum containing CPP-ACP was compared to two sugar free gums 
without CPP-ACP and the results showed that this product allowed higher 
remineralisation than the non-supplemented sugar free-gums after 14 days treatment. 
The remineralisation obtained with Trident White
TM
 gum was 107% and this was 75% 
higher than with the regular chewing–gums, Orbit and Orbit Professional, respectively 
[Manton et al., 2008]. Similar results were found with chewing gum containing urea 
where lesion depth in situ were reduced by 10.1% in the presence of 47 mg CPP-ACP 
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[Itthagarun et al., 2005]. Urea can be degraded by bacteria in the plaque into ammonia, 
which raises plaque pH.  
Another clinical study was carried out with sugar-free chewing gums containing CPP-
ACP to remineralise lesions on human teeth mounted on oral appliances. This clinical 
trial investigated the acid resistance of enamel lesions remineralised in situ with sugar-
free chewing gum containing 18.8 mg of CPP-ACP (Recaldent™) [Iijima et al., 2004]. 
The remineralisation determined on the subsurface lesions of palatal appliances after 8 
and 16 h of acid challenge was about two times higher with the Recaldent
TM
 chewing 
gum as compared to a chewing gum without CPP-ACP. When the appliances were 
subjected to a second acid challenge, the remineralisation was similar both with the 
CPP-ACP and the control chewing gums. The demineralisation was seen more 
underneath the remineralised zone, which indicated that the enamel remineralised with 
CPP-ACP was possibly more resistant to acid challenge than normal enamel. However, 
the composition of both enamels may differ, normal enamel has been reported to be 
calcium deficient and made of carbonated apatite that is less resistant than 
hydroxyapatite [Iijima et al., 2004]. Contradictory results were found in a similar study 
that was conducted in situ with bovine enamel slabs with subsurface lesions. The human 
subjects chewed 4 gums daily over a period of 14 days [Schirrmeister et al., 2007]. No 
benefit of CPP-ACP gums could be demonstrated in this study. 
5.3. Influence of foods supplemented with CPP-ACP on teeth remineralisation 
Milk and dairy products, especially cheese, naturally display an anticariogenic or 
cariostatic effect [Cross et al., 2006; Gupta and Prakash, 2011; Kashket and de Paola, 
2002] which may be explained by the intrinsic presence of casein and calcium 
phosphate. Nevertheless, most of the calcium present in milk is bound to casein 
micelles, therefore, addition of CPP-ACP to milk has been proposed as a means to 
increase the bioavailability of calcium ions. Yoghurt supernatants obtained after 
centrifugation of yoghurt were used as a natural source of CPPs. Teeth specimens were 
subjected to demineralisation with lactic acid and then immersed for 96 h in yoghurt 
supernatants [Ferrazzano et al., 2008]. This resulted in an increase in enamel 
remineralisation as compared to control teeth that were not in contact with the yoghurt 
supernatants. Direct addition of CPP-ACP to milk has been attempted to achieve an 
enhanced remineralisation of the tooth subsurface in situ [Walker et al., 2006; Walker et 
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al., 2009]. Three treatments were applied to subjects wearing removable appliances with 
attached enamel slabs containing subsurface lesions. The treatments consisted of a daily 
consumption of milk without CPP-ACP (Treatment 1), milk with 0.2% CPP-ACP 
(Treatment 2) and milk with 0.3% CPP-ACP (Treatment 3) over 15 days [Walker et al., 
2009]. In a previous study, the same approach was followed with a control that 
consisted of milk, and two other treatments with milk containing 0.2 and 0.5% (w/v) 
CPP-ACP [Walker et al., 2006]. In both studies, remineralisation of the slabs was 
observed for the three treatments. Nevertheless, higher remineralisation was obtained in 
the presence of CPP-ACP with an increase by 81 and 164% for Treatments 2 and 3, 
respectively, as compared to Treatment 1 [Walker et al., 2009]. The extent of 
remineralisation observed for the 0.2 and 0.5% CPP-ACP was reported to be 70 and 
148% higher than for milk in the other study [Walker et al., 2006]. Milk naturally 
enhances remineralisation of enamel subsurface, which is in agreement with its 
anticariogenic properties. Addition of CPP-ACP to milk allows an increased 
remineralisation of the enamel surface in a dose dependant manner. It has been 
proposed that owing to its intrinsic remineralisation properties, milk could be a better 
carrier for enamel remineralisation agents as compared to other vehicles [Walker et al., 
2009]. 
Food products such as sugar confectionaries have been utilised in an in situ study as a 
vehicle for CPP-ACP [Walker et al., 2010]. The addition of CPP-ACP in the sugar 
confectionary resulted in an increase in the mineral content of both the surface and body 
of the teeth lesions with a dose dependant effect on the remineralisation observed on the 
lesions. When CPP-ACP was added to sugar-free and sugar containing confectionaries, 
differences were observed with the remineralisation being more effective with the 
sugar-free confection. In the presence of sugar, the pH of the enamel slabs decreased 
below pH 5.5, where remineralisation was less effective. Based on the above results, 
formulations of sugar confectionaries with CPP-ACP have been proposed as a means to 
decrease their cariogenicity [ten Cate, 1999]. 
 
The prevalence of dental erosion has been associated with an increase in the 
consumption of soft drinks. Therefore, CPP-ACP was formulated into acidic soft drinks 
in order to assess its influence on dental erosion. The addition of 0.2% (w/v) CPP-ACP 
to acidic soft drinks decreased erosion depth in comparison to soft drinks without CPP-
 30 
 
ACP [Manton et al., 2010]. This result suggests that CPP-ACP could be added to soft 
drinks in order to reduce their erosive potential. 
 
 
In summary, numerous studies have been conducted in vitro and in situ to assess the 
remineralising potential of CPP-ACP delivered in the format of oral pastes, adjuncts for 
the oral hygiene or foods. The outcome of most studies support the positive role of 
CPP-ACP and CPP-ACFP as prophylactic agents for caries, erosion and white spot 
lesions. Although some contradictory results are seen in the literature, differences in 
study outcomes seem to arise from the protocol set up, notably, the exposure time of 
teeth to CPP-ACP appears to be a crucial parameter for bioactivity. The vehicle also 
plays an important role in the efficacy of CPP-ACP. From most studies carried out in 
vitro and in situ to date, there seem to be a strong evidence for CPPs bioactivity in the 
oral cavity. 
 
6. Role of CPP-ACP in combating the formation of biofilms 
A wide range of bacteria is naturally found in the oral cavity in the mucosa and dental 
plaque [Marsch et al., 2011; Pitts and Wefel, 2009]. These bacteria are organised in a 
biofilm adhering onto the tooth surface [Marsch et al., 2011]. They are characterised by 
their ability to produce acid following the fermentation of dietary carbohydrates. This 
acidification is responsible for enamel demineralisation [Aimutis, 2004; Cross et al., 
2007a; Hannig and Hannig, 2010]. The use of antibacterial agents has been proposed to 
control the development of dental plaque [Chen and Wang, 2010]. As already outlined, 
evidence on the positive role of CPP-ACP complexes against the formation of plaque 
has been well established [Rahiotis et al., 2008; Rose, 2000]. CPP-ACP mainly acts on 
the plaque through its buffering capacity, counteracting the pH reduction caused by 
bacterial growth at plaque level. The advantage of using CPPs as antimicrobial agents to 
combat the development of dental plaque is that they are natural agents and are not 
associated with the major drawbacks of antibiotics, i.e., the development of bacterial 
resistance to therapeutic agents and undifferentiated killing of bacteria [Chen and 
Wang, 2010]. 
 
 31 
 
6.1. The buffering capacity of CPP-ACP at the plaque level 
Caries risk is generally assessed by the measurement of pH in the dental plaque 
[Caruana et al., 2009]. CPP-ACP act by binding to the hydroxyapatite and diffusing 
inside of the dental plaque where it exhibits a buffering capacity and increases calcium 
content [Chen and Wang, 2010]. The buffering capacity of CPP-ACP is useful in 
countering the pH reduction provoked by acidogenic bacteria at plaque level. This effect 
of CPP-ACP has been demonstrated following carbohydrate challenge in a short term 
study conducted in vivo with human subjects utilising a toothpaste (GC Toothpaste) 
containing CPP-ACP [Caruana et al., 2009]. The impact of CPP-ACP after a 
carbohydrate challenge was studied using a micro-touch method based on a miniature 
pH electrode [Caruana et al., 2009]. The application of GC Tooth paste prior to the acid 
challenge reduced the decrease in plaque pH. Average plaque pH was 5.0 without the 
application of CPP-ACP paste versus pH 5.8 when CPP-ACP was used. In contrast no 
conclusive effect of CPP-ACP was found after 3 weeks of utilisation by 25 patients 
wearing fixed orthodontic appliances [Marchisio et al., 2010]. The procedure used in 
this study was nevertheless unclear as details are missing notably regarding the way in 
which Tooth Mousse was applied on the teeth and regarding other procedures used for 
subject oral hygiene such as the utilisation of fluorinated toothpaste. Additionally, this 
clinical trial did not include a control group, which makes the interpretation of the 
results more difficult. The authors concluded that no clear short-term effect of CPP-
ACP could be seen. 
A protective effect of CPP on the disruption of hydroxyapatite crystals with acids was 
demonstrated in the absence of bacteria [Kanekanian et al., 2008]. This suggests that 
CPP may adsorb at the surface of hydroxyapatite via physicochemical interactions, 
forming a layer allowing CPPs to display their protective effect. Protection of 
hydroxyapatite was shown to follow a dose dependant pattern and was maximal at a 
CPP concentration of 10 mg.mL
-1
. No differences in terms of hydroxyapatite protection 
could be seen with CPPs saturated with calcium and with CPPs where 70% of the 
calcium was removed suggesting that the protection of hydroxyapatite was not achieved 
through a buffering capacity of Ca but through that of CPPs [Kanekanian et al., 2008]. 
Nevertheless, calcium and phosphate ions have an indirect role on pH control at the 
enamel level, as the deposition of ions can reduce the diffusion of plaque acids in the 
enamel [Peters, 2010]. 
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6.2. Interactions of CPP-ACP with the dental plaque biofilm 
It has been demonstrated that CPP-ACP can directly bind the bacteria surface [Cross et 
al., 2006]. The binding of CPP-ACP at the bacterial surface may be specific as the 
binding was not the same depending on the bacterial strain. Binding of CPP-ACP to 
bacterial cells was established directly with the bacterial cell surface [Reynolds et al., 
2003]. At the bacterial cell and pellicle surface, binding may involve hydrophobic 
interactions and hydrogen bonds [Reynolds et al., 2003]. Binding of CPP-ACP to the 
dental plaque resulted in an increase in the Ca and Pi levels when mouthrinse was 
utilised by human subjects, leading to a 118 and 57% increase in Ca and Pi, 
respectively. At the plaque level, CPP-ACP acts as a reservoir of soluble calcium 
phosphate ions that can diffuse into the enamel subsurface to promote remineralisation 
[Reynolds et al., 2003]. After incorporation in the dental plaque, CPPs can remain at 
relatively high levels. Three hours after the consumption of chewing gums containing 
CPP-ACP, the level of CPPs in the plaque was 4.6 fold higher than in a control baseline 
plaque [Reynolds et al., 2003]. A half-life of 124.8 min has been reported for CPP in the 
plaque [Cochrane et al., 2010]. The time–dependant decrease in CPP concentration in 
plaque may be due to the action of enzymes from the dental plaque (peptidases and 
phosphatases) that can degrade CPPs [Reynolds et al., 2003]. 
CPP-ACP has been shown to reduce calcium diffusion in a streptococcal model plaque 
from Streptococcus mutans R9 isolated from human caries. This decrease in calcium 
diffusion allowed a potential reduction of calcium loss from the plaque and therefore 
increases the availability of calcium that could participate in remineralisation of the 
enamel surface [Rose, 2000], An average of 3 Ca
2+
 per CPP-ACP unit can bind to 
bacterial cells, corresponding to a binding capacity of 0.16 g CPP-ACP/g wet wt cells at 
pH 7. This number depends on the pH: at pH 5, which mimics the acidic conditions 
prevailing during carious infections, the binding capacity decreases to 0.11 g/g wet wt 
cells due to a reduction in the overall charge of the CPP-ACP complex, reducing 
binding sites for CPP-ACP. This resulted in an increase in calcium diffusion in the 
plaque at pH 5 as compared to pH 7 [Rose, 2000]. 
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Germanium (Ge) crystals mounted on orthodontic appliances with a custom-made 
retainer have been used to study the formation of biofilms after treatment of the crystals 
with Tooth Mousse (containing 10 wt% CPP-ACP complex) in situ [Rahiotis et al., 
2008]. The orthodontic appliances were retained in the oral cavity of the subjects for 
different periods of time ranging from 30 min to 1 week. The formation of biofilms on 
the untreated Ge crystals was observed as early as 30 min, whereas biofilm formation 
with the CPP-ACP treated Ge only started after 24 h. CPP-ACP complexes that adsorb 
at the enamel surface may cause an increase in the negative net charge, which act as 
repulsion forces for micro-organism attachment to the enamel surface. CPP-ACP 
crystals appeared at the surface of Ge treated appliances, with crystal growth 
(nucleation and crystallisation) increasing over time [Rahiotis et al., 2008]. The 
conclusion from this work has to be carefully extrapolated to tooth surfaces. It has been 
pointed out by other authors [Hannig and Hannig, 2010], that in contrast to the tooth 
surface, Ge is not a biomineral (mineral naturally produced in living organisms) and 
may therefore react differently. 
 
In summary, CPP-ACP may help combat dental plaque as it can directly bind to plaque 
bacteria surfaces and protect hydroxyapatite through its buffering capacity. This binding 
may involve hydrophobic interactions and hydrogen bonds. CPP-ACP also reduces 
diffusion of calcium and phosphate ions in the plaque allowing longer residence in the 
plaque to remineralise carious lesions and also contribute to the buffering capacity. A 
long half-life time for CPP-ACP (124.8 min) has been demonstrated in dental plaque, 
which may be relevant for sustained bioactivity in the oral cavity over time. 
7. Other applications of CPP-ACP: therapeutic uses in dental treatment 
Most of the applications of CPP-ACP described in the literature have targeted oral 
hygiene and more particularly the regression of dental caries and erosion via 
remineralisation and a decrease in demineralisation together with dental plaque 
regression. 
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7.1. Dentin hypersensitivity 
Other applications of CPP-ACP are found for treatment of dentin hypersensitivity. 
Successful application of CPP-ACP to reduce the pain experienced by subjects 
susceptible to dentin hypersensitivity has been reported [Kowalczyk et al., 2006]. 
Dentin hypersensitivity was reduced in an in vivo study carried out with 13 patients 
when a CPP-ACP paste was used as a topical treatment [Kowalczyk et al., 2006]. The 
elimination of pain could be seen in 28% of the teeth following the treatment. 
Nevertheless, this effect appeared to be limited in time as the sensation of pain was 
experienced again as early as 7 days after discontinuation of the application of CPP-
ACP (with around 12% of the teeth showing no pain sensation). Despite its effect on 
dentin hypersensitivity, CPP-ACP was not as efficient as other agents already on the 
market [Kowalczyk et al., 2006]. In an in vivo study including 48 patients, 
hypersensitivity following scaling and root planning was also significantly reduced 
following the application of Tooth Mousse. The reduction of discomfort observed with 
Tooth Mousse was significantly higher than the control over a period of 10 days 
[Gugnani et al., 2008]. In another in vivo study, no benefit of CPP-ACP could be 
demonstrated. Following a whitening procedure, tooth sensitivity was significantly 
reduced with subjects using sugar free-gums within the 24 h of the treatment. 
Nevertheless, no significant difference was seen between the groups using sugar free-
gums with or without CPP-ACP [Tang and Millar, 2010]. 
7.2. Alvusion injury 
CPP-ACP has also been successfully used in alvusion injuries, which is a traumatic 
dental injury characterised by complete displacement of the tooth from the alveolar 
socket, followed in some cases by an injury to the periodontal ligament (PDL) [Cehreli 
et al., 2008]. The alvused teeth can be re-implanted, nevertheless, there is a need for a 
re-implantation medium to maintain viability of the PDL cells. Milk has been reported 
to support PDL cell viability, therefore, Cehreli et al. [2008] tested the efficacy of CPP-
ACP present in Tooth Mousse as a re-implanting medium for PDL cells. They studied 
the effect of different dilutions of Tooth Mousse (CPP-ACP) on the viability of cultured 
L929 fibroblasts which have similar physiological and morphologic characteristics as 
gingival fibroblasts. The effects on cell proliferation depended on the dilution of Tooth 
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Mousse used. No cell proliferation was observed between 1 and 3 days for dilutions 10
-3
 
and 10
-4
, whereas for the other dilutions tested (10
-6
, 10
-8
 and 10
-12
), an increase in cell 
count was observed within 1-3 days. A so-called “toxic threshold” was observed for 
longer periods (7 days), the cell count was decreased for dilutions 10
-3
 to 10
-6
, whereas 
for the other dilutions (10
-8
 and 10
-12
), the cell count remained the same as at day 3. 
Apoptosis was seen for all dilutions except for 10
-12
. This toxic effect was attributed to 
the increased amount of calcium and other ingredients and additives present in the 
Tooth Mousse (glycerol, polypropylene glycol, phosphoric acid, etc.) with higher 
concentrations of CPP-ACP, interfering with cell proliferation and apoptosis. 
Furthermore, deposition of CPP-ACP was observed at the cell surface with the highest 
concentration of Tooth Mousse used, which may explain the toxic effect. This study 
concluded that low concentrations of CPP-ACP could therefore be used to maintain the 
viability of the PDL in vitro. 
7.3. Modification of shear bond stress (SBS) 
Another potential application of CPP-ACP is for brackets and modification of the SBS 
involved. Shear bond stress corresponds to the force required to dislodge orthodontic 
brackets from teeth. Depending on the type of orthodontic brackets, a high or a low SBS 
is desirable. For ceramic brackets, the SBS should not be too high to avoid damaging 
the teeth during debonding, whereas for metal brackets, a higher SBS is desirable as the 
bond must be strong enough in regard to the forces applied during orthodontic treatment 
[Bishara, 2000]. CPP-ACP has been studied mainly with metal brackets to increase 
SBS. SBS was evaluated with human [Baysal and Uysal, 2011; Tabrizi and Cakirer, 
2011; Uysal et al., 2011; Xiaojun et al., 2009] and bovine teeth [Kecik et al., 2008]. An 
increase in bond strength was found for bovine teeth when applying CPP-ACP paste, 
fluoride plus CPP-ACP or acidulated phosphate fluoride (APF) as compared to the 
control teeth where no pre-treatment was applied [Kecik et al., 2008]. No significant 
difference for the SBS was found with the 3 treatments (CPP-ACP paste, fluoride plus 
CPP-ACP and APF). On the contrary, when using human teeth, the fluoride treatment 
resulted in a decrease in SBS as compared to the control while CPP-ACP and fluoride 
plus CPP-ACP did not modify SBS. An increase in the SBS was seen in the presence of 
CPP-ACP when human teeth were previously demineralised following a microabrasion 
procedure which may be used in the management of WSL [Baysal and Uysal, 2011]. In 
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another study, pre-treatment with CPP-ACP resulted in an increase in SBS for human 
teeth or no significant difference as compared to the control was found depending on 
the type of bonding adhesive used [Xiaojun et al., 2009]. Similar results were found 
where no significant difference for SBS  of bonding systems could be observed between 
human teeth controls and teeth pre-treated with CPP-ACP [Uysal et al., 2011; Zorba et 
al., 2010]. The pre-treatment of the teeth with CPP-ACP is reported to result in a 
rougher etched enamel surface, which may be responsible for a greater adhesiveness 
and better bonding of resin tags of the brackets [Xiaojun et al., 2009]. The outcome of 
these different studies is not clear as they do not agree with each other. This research 
area investigating the effect of CPP-ACP on SBS is relatively new and more 
standardised procedures will help to better understand the impact of CPP-ACP on SBS. 
 
 
 
Different bioactive properties of CPP-ACP in the oral cavity have been discussed based 
on the numerous outcomes of in vitro and in situ studies. These bioactivities can be 
classified in 4 categories including the remineralisation, prevention of demineralisation, 
anti-plaque and other bioactivities (Figure 5). To date, most studies carried out on the 
role of CPP in the treatment of dental caries have been conducted on mammalian teeth 
in vitro and in situ [Azarpazhooh and Limeback, 2008; Cai et al., 2003; Zero, 2009]. In 
1995, it was already reported that most commonly applied methods in dental research 
had been carried out in vitro [White, 1995]. Despite numerous studies carried out in 
situ, a similar situation is found today, as very little has been done in vivo so far. The 
limitation of the in vitro models come from the fact that they do not reproduce the 
biological intra oral conditions associated with caries, nor the intra-oral surface area 
(volume and composition of saliva and tooth surface) and finally, they are associated to 
artefacts originating from the dental substrate choice (i.e., faster time periods of 
demineralisation and remineralisation as compared to the in vivo situation, dental 
substrate choice that can affect its reactivity to the protocol applied) [White, 1995]. 
Some clinical trials demonstrated the anticariogenic role of CPP-CP (calcium 
phosphate) using rat models [Guggenheim et al., 1999; Reynolds et al., 1995]. Many 
human intervention studies on the remineralising potential of CPP-ACP have been 
conducted (Table 5). Most of these trials concluded in a positive role of CPP-ACP on 
 37 
 
teeth health. Nevertheless, a few studies have reported no benefit of using CPP-ACP 
[Beerens et al., 2010; Brochner et al., 2011] and other studies obtained results which 
were contradictory [Altenburger et al., 2010]. The outcomes of these human 
intervention trials will be discussed in the following section. 
8. Contradictory results on the remineralising potential of CPPs 
Despite numerous studies dealing with the efficiency of ACP-CPP to combat the 
development of dental caries and erosion, there are still some controversy on the 
efficiency of this ingredient. In a recent review addressing non-invasive strategies for 
tooth repair, Peters [2010] reported the fact that there was a lack of strong clinical 
evidence on the remineralising effect of CPP-ACP.  
8.1. Major outcomes of reviews and meta-analyses on the remineralising 
potential of CPP-ACP 
The publication of several systematic reviews and meta-analyses on the remineralising 
properties of CPP-ACP demonstrate that the scientific community has a significant 
interest in the area [Cochrane et al., 2010; Gupta and Prakash, 2011; Pitts and Wefel, 
2009; Reynolds, 2009; Yengopal and Mikenautsch, 2009; Zero, 2009]. A systematic 
literature survey on the teeth remineralising properties of CPP-ACP was conducted 
[Azarpazhooh and Limeback, 2008]. Out of ten articles dealing with the remineralising 
properties of CPP-ACP, 8 were conducted in situ and 2 in vivo. In seven of these trials, 
the same conclusion was reached, showing a remineralisation of the enamel, which 
followed a dose-response pattern. Nevertheless, two studies did not show any additional 
benefit of utilising CPP-ACP for the prevention of dental caries and one study led to 
conflicting results [Azarpazhooh and Limeback, 2008]. Comprehensive reviews on the 
remineralising properties of CPP-ACP have suggested a lack of independent scientific 
research in the area [Azarpazhooh and Limeback, 2008; Yengopal and Mikenautsch, 
2009; Zero, 2009]. Most trials concluding in a positive role of CPP-ACP for the 
treatment of dental caries have been carried out by a research team which has been 
involved in the patenting of CPP-ACP complexes. Nevertheless, several independent 
studies leading to a positive effect of CPP-ACP have recently been published as 
outlined in different review articles [Gupta and Prakash, 2011; Pitts and Wefel, 2009]. 
However there are still some conflicting results, making it difficult to draw definitive 
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conclusions regarding the efficacy of CPP-ACP for the prevention of dental caries 
[Azarpazhooh and Limeback, 2008]. 
Reynolds [2009] compiled a review to demonstrate the scientific evidence around the 
utilisation of CPP-ACP in oral hygiene. The scientific evidence was based on a series of 
facts that have been demonstrated in the literature arising from his research group and 
from that of other groups. A summary of the evidence reported to date is as follows:  
 CPP-ACP is efficient in remineralising and inhibiting the demineralisation of the 
tooth enamel subsurface. 
 CPP-ACP can increase the availability of ions (including calcium) at the surface 
of the tooth and bind to bacteria localised in the plaque. 
In the two reviews from Azarpazhooh and Limeback [2008] and Zero [2009], it was 
advised to conduct more randomised controlled trials (RCT) in order to determine the 
long-term effect of the utilisation of CPP-ACP by human subjects as the first RCT with 
CPP-ACP had been carried out by Reynolds et al. [2003]. The authors also suggested 
that more independent studies were needed in the area. 
8.2. Evaluation of the remineralisation potential of CPP-ACP in vivo 
A literature search has been conducted for the period 2005-2012 on the databases 
MEDLINE, Science Direct and Google scholar. The search terms were as follows: 
“CPP-ACP”, “clinical trial”, “in vivo”. Additionally, other references were found in 
different review papers dealing with the remineralising properties of CPP-ACP 
[Cochrane et al., 2010; Gupta and Prakash, 2011; Reynolds, 2009; Yengopal and 
Mikenautsch, 2009; Zero, 2009]. This analysis revealed that to date twenty two different 
in vivo clinical trials with CPP-ACP have been carried out on human subjects 
[Altenburger et al., 2010; Andersson et al., 2007; Ardu et al., 2007; Bailey et al., 2009; 
Baroni and Marchionni, 2011; Beerens et al., 2010; Brochner et al., 2011; Caruana et 
al., 2009; Ferrazzano et al., 2011; Gugnani et al., 2008; Kitasako et al., 2010; 
Kowalczyk et al., 2006; Marchisio et al., 2010; Milnar, 2007; Morgan et al., 2008; Rao 
et al., 2009; Reynolds et al., 2008; Reynolds et al., 2003; Robertson et al., 2011; Tang 
and Millar, 2010; Uysal et al., 2010; Zhou et al., 2009]. Within these trials, sixteen 
(Table 5) studied the remineralising properties of CPP-ACP [Altenburger et al., 2010; 
Andersson et al., 2007; Ardu et al., 2007; Bailey et al., 2009; Baroni and Marchionni, 
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2011; Beerens et al., 2010; Brochner et al., 2011; Ferrazzano et al., 2011; Kitasako et 
al., 2010; Morgan et al., 2008; Rao et al., 2009; Reynolds, 2008b; Reynolds et al., 2003; 
Robertson et al., 2011; Uysal et al., 2010; Zhou et al., 2009].  
These clinical trials included follow-up periods of up to several years, i.e., 2 [Kitasako 
et al., 2010; Morgan et al., 2008] and 3 years [Baroni and Marchionni, 2011]. These 
studies supported the fact that CPP-ACP have a long-term effect for the prophylaxis of 
caries and WSL [Yengopal and Mikenautsch, 2009]. Out of the 16 human intervention 
trials discussed in this section, five studied caries regression [Altenburger et al., 2010; 
Morgan et al., 2008; Rao et al., 2009; Reynolds et al., 2008; Reynolds et al., 2003], 
while nine studied the action of CPP-ACP on the remineralisation of WSL appearing 
post orthodontic appliances [Andersson et al., 2007; Ardu et al., 2007; Bailey et al., 
2009; Beerens et al., 2010; Brochner et al., 2011; Kitasako et al., 2010; Robertson et al., 
2011; Uysal et al., 2010; Zhou et al., 2009], one studied the effect of CPP-ACP on 
molar incisor hypomineralisation (MIH) [Baroni and Marchionni, 2011] and another 
studied the effect of CPP-ACP on remineralisation of demineralised and non-
demineralised human teeth specimens attached to the teeth of human subjects 
[Ferrazzano et al., 2011]. 
The localisation of CPP-ACP at plaque level was demonstrated in a RCT where subjects 
were instructed to chew gums containing CPP-ACP [Reynolds et al., 2003]. In the same 
study, the positive role of CPP-ACP on the localisation of calcium and phosphate ions 
in the plaque was shown following the use of a mouth wash formulated with CPP-ACP 
[Reynolds et al., 2003]. The effect of CPP-ACP on caries regression has been studied in 
a clinical trial that was conducted on 2720 teenagers where the efficiency of a sugar free 
gum containing 54 mg CPP-ACP was tested versus a sorbitol-based sugar-free gum 
(control) [Morgan et al., 2008]. During the trial, the subjects brushed their teeth with 
fluorinated toothpaste and were exposed to fluorinated drinking water. The approximal 
caries surface reduction was 17% more with the CPP-ACP group as compared to the 
control group. Additionally, some evidence of remineralisation of both the enamel and 
dentin were seen through the regression of surface lesions with the CPP-ACP gum. A 
fluorescent non-destructive technique: DIAGNOdent was used in vivo to monitor early 
carious lesions [Altenburger et al., 2010]. The application of Tooth Mousse on carious 
lesions over a period of 3 weeks resulted in a decrease in the fluorescence value 
compared to a fluoride toothpaste. This decrease was correlated with a reduction of 
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enamel surface porosity [Altenburger et al., 2010]. Nevertheless, no differences could 
be seen when a visual assessment of the fissures was carried out. Because of these 
contrasting results, the authors concluded that CPP-ACP may be used as an adjunct for 
the prophylaxis of occlusal fissures [Altenburger et al., 2010]. Most studies carried out 
to date have utilised commercial ingredients or products containing CPPs. Very few 
reported the utilisation of in-house generated CPPs. However in the RCT conducted by 
Rao et al. [2009], the CPPs were manufactured at laboratory-scale before being 
incorporated in a toothpaste. The RCT reported a decrease in decayed surface when 
CPP-ACP or sodium monofluorophosphate (SMFP) toothpastes were used. Less new 
lesions occurred in children with the CPP-ACP and SMFP toothpastes as compared to 
these using the placebo toothpaste [Rao et al., 2009].  
Recently, Ferrazzano et al. [2011] developed an in situ model using the natural 
environment of the oral cavity of human subjects for the evaluation of CPP-ACP 
efficacy. However, because the subjects wore enamel specimens attached to their teeth 
using an adhesive procedure, this approach has been classified as an in vivo study. Two 
human enamel specimen which went through a demineralisation procedure were placed 
on the teeth of healthy adolescents. Topical application of a paste (Tooth Mousse or a 
placebo) was carried out three times daily over a month. The design of this human trial 
was interesting as it included a control group where the subjects were also equipped 
with either a sound or a demineralised enamel specimen and were using their normal 
oral hygiene routine. Additionally, all the conditions tested in vivo were also tested in 
vitro. SEM analysis revealed the formation of an amorphous deposit at the 
demineralised tooth surface after CPP-ACP treatment. The deposit was entirely filling 
the lesions. This result demonstrated the potential of CPP-ACP as a remineralising 
agent which could help combat dental caries [Ferrazzano et al., 2011]. 
The positive role of CPP-ACP as a topical treatment (5 min application) was 
demonstrated in vivo in adolescents with orthodontic brackets [Uysal et al., 2010]. The 
remineralisation around the brackets was investigated using micro-hardness analyses 
with subjects scheduled for a premolar teeth extraction for orthodontic reasons. CPP-
ACP allowed remineralisation around orthodontic brackets, the same level of 
remineralisation was achieved with the application of a fluoride gel [Uysal et al., 2010]. 
In adolescent subjects, CPP-ACP present in Topacal C5 [Andersson et al., 2007] was 
applied for 3 months followed by 3 month utilisation of fluorinated toothpaste (1000-
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1100 ppm). This treatment gave better results for the disappearance of WSL as 
compared to the control group where subjects were instructed to use a fluorinated mouth 
wash and toothpaste for the same duration. Differences between the test and the control 
group were already seen after 1 month treatment with a regression of WSL being more 
marked in the presence of CPP-ACP. The proportion of white lesion sites that totally 
disappeared was of 55% with the CPP-ACP treatment and 18% for the control after 6 
months. These were of 63% (CPP-ACP treatment) and 25% (control) after the 12 month 
follow-up period. Similarly, another study found that 31% more lesions had regressed 
with the remineralising cream (Tooth Mousse/MI Paste) than with the placebo at 12 
weeks [Bailey et al., 2009]. Reduction in enamel demineralisation was also 
demonstrated in vivo with orthodontic patients after the utilisation of Tooth Mousse 
[Zhou et al., 2009]. The use of CPP-ACP paste to improve the aesthetic appearance of 
teeth after bracket debonding was described. A combination of microabrasion and a 
topical treatment with CPP-ACP paste (Tooth Mousse) resulted in the disappearance of 
superficial WSL [Ardu et al., 2007]. Similarly, the utilisation of MI Paste Plus after 
teeth brushing with a fluoride paste reduced enamel decalcification index by 53.5 %. 
This showed the influence of CPP-ACP both on a reducing the number of WSL and in 
their prevention [Robertson et al., 2011]. Recently, Kitasako et al. [2010] developed a 
micro pH sensor consisting of a solid state electrode to monitor pH changes directly at 
the surface of the tooth lesion to study the influence of CPP-ACP treatment in a clinical 
trial over a 24 month period. Kitasako et al. [2010] monitored pH changes in white spot 
enamel lesions (WSEL) using a micro pH electrode in 8 human subjects who received a 
treatment with MI Paste over a period of 24 months. There was no progression to 
cavitation of the WSEL and the appearance of the lesions visually improved, possibly 
due to the remineralising effect of CPP-ACP. The treatment showed an increase in the 
pH of the WSEL over time (5.94 at 0 month vs. 6.70 after 24 months) toward pH values 
for sound enamel (6.80 at time 0 vs. 6.83 after 24months). The pH increase in the 
WSEL was attributed to either a better access of the saliva to the lesion or to the 
buffering capacity or remineralisation action of the CPP-ACP in the plaque and the 
WSEL. 
CPP-ACP was shown to improve the appearance of MIH in children who received a 
daily topical application of GC Tooth Mousse [Baroni and Marchionni, 2011]. The 
remineralisation of MIH improved over a 3 year period, leading to increased levels of 
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calcium and phosphate. Microscopic analysis also revealed that the enamel structure 
improved, with a smoother enamel surface and an improved porosity. 
In another RCT study no significant effect of CPP-ACP on the improvement of WSL 
could be demonstrated. Tooth Mousse was used for topical applications on WSL in 
combination with normal tooth brushing with fluoride toothpaste. The control group 
brushed their teeth with the fluorinated toothpaste only [Brochner et al., 2011]. The 
authors found no statistically significant difference in the regression of the lesions 
between both groups after 4 weeks treatment (56% mean area decrease in WSL for the 
group treated with CPP-ACP versus 26% for the control group) despite a trend showing 
a greater effect of the CPP-ACP treatment. Nevertheless, the relatively short time over 
which the study was carried out (4 weeks) and the size of the group (60 subjects) may 
explain why no statistically significant differences were seen between the CPP-ACP 
group and the control group. Similarly, no improvement in the WSL size or the plaque 
composition was seen with adolescents using CPP-ACFP as a topical treatment after 
debonding of their orthodontic appliances [Beerens et al., 2010]. 
Within the in vivo studies described in the scientific literature (Table 5), five clinical 
trials have been conducted by Reynolds’ group [Bailey et al., 2009; Kitasako et al., 
2010; Morgan et al., 2008; Reynolds et al., 2008; Reynolds et al., 2003] while eleven 
other trials have been performed by different groups [Altenburger et al., 2010; 
Andersson et al., 2007; Ardu et al., 2007; Baroni and Marchionni, 2011; Beerens et al., 
2010; Brochner et al., 2011; Ferrazzano et al., 2011; Rao et al., 2009; Robertson et al., 
2011; Uysal et al., 2010; Zhou et al., 2009]. Around 80 % (13 out of 16 in vivo human 
interventions) of the clinical trials reported a positive role of the CPP-ACP complex on 
the remineralisation of teeth (Table 5). The study of Brochner et al. [2011] showed a 
positive role, but the results obtained with CPP-ACP were not statistically significantly 
different from the control (fluoride). Similarly, Altenburger et al. [2010] demonstrated a 
beneficial effect of CPP-ACP on the regression of fissures, but this could only be 
measured instrumentally and was not confirmed following a visual inspection of the 
teeth. However, one study did not show any additional benefit of CPP-ACFP on the 
improvement of WSL [Beerens et al., 2010]. In addition, a number of in vitro and in situ 
trials have also concluded in the inefficacy of CPP-ACP to remineralise teeth surfaces 
[Lata et al., 2010; Rehder Neto et al., 2009; Schirrmeister et al., 2007; Wang et al., 
2011; Wegehaupt and Attin, 2010; Wegehaupt et al., 2011]. 
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8.3. Possible origin for the contradictory results 
Contradictory results seem to arise mainly from the methodology utilised to conduct 
trials, notably the type of dental appliances used. According to Zero [2009], the studies 
conducted by Reynolds’ group were carried out in conditions that are not representative 
of demineralisation/remineralisation situations in the human mouth. The enamel slabs 
on the appliances were not positioned in caries prone teeth sites as these were in contact 
with the tongue (palatal appliances). The location of the appliances affects the degree of 
remineralisation, as contact with chewing gum varies depending on the location of the 
teeth. This may be the reason why the results observed in an in situ experiment where 
the appliances were positioned in mandibular appliances were different. This study 
showed no benefit of chewing gums containing CPP-ACP on teeth remineralisation as 
there was no direct contact of the chewing gum with the lesions [Schirrmeister et al., 
2007]. Furthermore the term CPP-ACP has been incorrectly utilised in a number of 
instances. For example, Schirrmeister et al. [2007] used chewing gums containing 
casein/hydrolysed casein and calcium phosphate instead of CPP-ACP [Reynolds, 2009]. 
Other differences may arise from the depth of the lesions used. These were twice as 
deep in the study of Shen et al. [2001] as compared to the study of Schirrmeister et al. 
[2007]. Deeper lesions may allow the better detection of differences in terms of 
remineralisation. Another point is the relatively large standard deviation associated with 
the remineralisation measurements in the Schirrmeister et al. [2007] study, making it 
difficult to interpret the results. 
The manner in which appliances are utilised affects the remineralisation results. When 
appliances were removed during food and drink intake, this excluded the possibility to 
study the effect of acid erosion [Zero, 2009]. Nevertheless in a recent in situ study, 
enamel lesions presenting a plaque biofilm were subjected to frequent acid challenge 
induced during the consumption of sugar confections and remineralisation was still 
demonstrated in these conditions when CPP-ACP was added to the confectionaries even 
at levels as low as 0.5% (w/w) [Walker et al., 2010]. 
Another source of variation may arise from the treatment applied to the control group 
during different remineralisation trials. In two in vivo human intervention studies, the 
control groups used deionised water [Reynolds et al., 2008; Reynolds et al., 2003], 
 44 
 
which may have caused a demineralisation of the teeth and thus affected the outcomes 
of the studies. Zero [2009] raised the concern that most of the studies from Reynolds’ 
group have been carried out with CPP-ACP and fluoride. Nevertheless, Reynolds 
reported in his review that Recaldent
TM
 has been developed to be used in combination 
with fluoride as an adjunct for treatment of early stage caries development [Reynolds, 
2009]. This follows the suggestion of Pfarrer and Karlinsey [2009] who proposed that 
calcium containing technologies developed for tooth remineralisation must be used to 
augment fluoride action in the treatment of tooth decay and that possible interactions 
with fluoride should be addressed in order to maintain its activity. This wide variability 
in the protocols developed so far suggest that there is a need for more standardisation in 
the methodologies employed to assess CPP-ACP remineralising properties [Pitts and 
Wefel, 2009]. 
 
In their meta-analysis, Yengopal and Mickenautsch [2009] reported that in all the 
studies where lesions have been exposed to CPP-ACP, a significant improvement of 
remineralisation in respect to control lesions was observed. Similar conclusions were 
drawn by Gupta and Prakash in their recent comprehensive review on CPP-ACP [Gupta 
and Prakash, 2011]. Results obtained in situ suggest a short term effect of the 
remineralisation observed with CPP-ACP [Yengopal and Mikenautsch, 2009]. The 
effective dose for short term trials has been found to be between 10 and 18.8 mg of 
CPP-ACP in sugar-free gums whereas long term studies have utilised a higher dose of 
CPP –ACP, i.e., 54 mg in sugar –free gums [Yengopal and Mikenautsch, 2009]. 
 
In summary, clinical trial outcomes seem to suggest the prophylactic role of CPP-ACP 
in the improvement of oral health in agreement with the numerous studies carried out in 
vitro and in situ [Gupta and Prakash, 2011]. However, it appears that stronger evidence 
is still needed to unequivocally recommend CPP-ACP in the non-invasive treatment of 
dental caries [Gupta and Prakash, 2011; Peters, 2010]. Nevertheless, CPP-ACP has 
significant potential as an adjunct to fluoride in the prevention of caries [Gupta and 
Prakash, 2011; Peters, 2010]. The conflicting scientific evidence in relation to the teeth 
remineralising properties of CPP-ACP may be related to differences in experimental 
protocols and in the relatively large variability found in some studies thus making 
interpretation of the results obtained challenging. An interesting in vivo model has 
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recently been developed by Ferrazzano et al. [2011], where human teeth have been 
fixed onto triallist teeth in order to study the remineralisation potential of CPP-ACP. 
The advantage of this model is that all attached teeth had previously gone through the 
same demineralisation procedure while in constant contact with the human oral cavity 
during the time frame of the study. This new model may help to provide more 
reproducible data on the effect of CPP-ACP in vivo. At present, very little is known 
about the long term effect of CPP-ACP in humans. The longest clinical trial reported to 
date is 3 years and the longest follow-up period is 24 months. There is a need to 
generate more knowledge on the possible long-term consequences of such ingredients 
on human oral/dental health. 
 
9. Conclusions 
The role of CPP’s has been discussed using a wide range of in vitro, in situ and in vivo 
studies to assess their biofunctionality mainly as mineral carriers in the oral cavity. 
CPPs play a role in the remineralisation process of teeth enamel, allowing the repair of 
lesions that can occur at the enamel and dentin level. The enamel formed in the 
presence of CPP-ACP appears to be more resistant than normal enamel. This 
observation is very interesting from the perspective of further slowing down or 
preventing the demineralisation process. A protective effect of CPP-ACP has been seen 
when incorporated into foods with erosive properties such as high sugar confectionary 
and low pH soft drinks. They have been successfully incorporated in a wide range of 
carriers ranging from oral hygiene products (toothpaste, mouth rinse), adjuncts for oral 
hygiene (chewing gums and lozenges) to actual foods. 
The application of CPPs as dental health enhancement agents present a major advantage 
over other bioactive peptides. Since their site of action is located in the mouth, it is less 
likely that they will be degraded as they can act as soon as they enter the oral cavity. A 
number of studies have nevertheless found contradictory results, showing no bioactivity 
of CPPs in the oral cavity or no synergistic action between fluoride and CPP-ACP. 
These differences may arise from the methodology employed to assess CPP bioactivity. 
The protocols employed should represent the conditions occurring in the oral cavity to 
extrapolate the efficiency of CPPs when they are used by human subjects. The 
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outcomes of different studies suggest that the residence time and an effective contact of 
CPP-ACP with the teeth may be crucial parameters in order to observe beneficial effects 
with CPPs. Therefore, the carrier employed for delivery of CPP-ACP can be an 
important factor in their bioactivity. A large amount of data has been generated on the 
efficacy of CPP-ACP in different carriers including foods. Nevertheless, very little is 
known about interactions between CPP-ACP and other food components in the oral 
cavity. In other words, the effect of a given diet or specific food consumption on CPP-
ACP bioactivity is still not very well understood. This aspect needs to be addressed to 
try to better understand the source of variation seen in different intervention trials 
conducted in humans. 
Various human intervention trials have been carried out evaluating the role of CPP-ACP 
on the remineralisation of enamel. Most of these trials (13 out of 16, which accounts for 
80%) concluded in a positive role of CPP-ACP on teeth remineralisation. The 
generation of universally accepted guidelines for the design of future human 
intervention trials may allow better comparison of different studies. It was earlier 
outlined, for example, that the residence time of CPP-ACP may significantly affect their 
efficacy. However, very little information in this regard has been outlined in many of 
the studies performed to date, while this parameter may be the key for bioactivity in the 
oral cavity; additionally, there is a need to generate more knowledge on the possible 
long-term consequences of such ingredients on human dental health. Although one 
could argue that CPPs are naturally formed within the human body, they generally 
appear in the gastrointestinal tract following milk concumption. Their addition in food 
and oral hygiene products consequently increases their concentration to a level not 
normally observed in the oral cavity of humans. CPPs effect on other tissues in the 
mouth may need to be studied in more details. Initial data suggesting that they can 
display cytotoxicity at high concentrations on PDL (periodontal ligament) cells and 
affect the viability of fibroblasts merits further study. Therefore, specific regulations 
may need to be developed regarding acceptable dosages of these ingredients in foods 
and oral hygiene products. 
The health issue represented by caries development and erosion seems to be correlated 
in most cases with poor oral hygiene practices. This issue needs to be tackled at source. 
A more focus development of public policies involving the producers of oral hygiene 
products and adjuncts for oral hygiene could be beneficial in order to stress the 
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importance of good oral hygiene procedures from an early age to ensure the 
development of lifelong healthy habits in the population. CPP-ACP can be used in 
parallel to help prevent the development of dental caries and erosion. This may be 
potentially relevant for those segments of the population, such as toddlers, infants and 
elderly, where brushing of teeth can be a challenging task. In addition, the use of CPP-
ACP in combination with fluoride may have potential to help avoid fluorosis in infants 
while combatting the development of dental caries. 
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Table 1 
 
Diet System (in vivo) CN origin Reference 
Casein Rat 
(small intestine) 
nd Naito et al. [1972] 
Casein Minipig 
(jejunal fluid)
s1- CN Meisel and Frister [1988] 
Milk/ yoghurt Human 
(stomach and duodenum)
s1/- CN Chabance et al. [1998] 
Milk/CPPs Human 
(ileostomy fluid) 
nd Meisel et al. [2003] 
(CN: casein; nd: not determined; CPPs: caseinophosphopeptides) 
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Table 2 
Patent Title Component Methods of production and extraction Benefit area Target 
 
Patent 
category 
U
S
4
,3
6
1
,5
8
7
 
[B
ru
le
 e
t 
al
.,
 
1
9
8
2
] 
Phosphopeptides from 
casein-based material 
Phosphopeptides originating 
from skimmed milk 
Enzymatic hydrolysis (Pancreatin
 
in the form of a 
natural pancreatic extract or mixtures of trypsin and 
-chymotrypsin) of skimmed milk. 
Membrane separation (UF) and disaggregation to 
isolate phosphopeptides from the proteolytic enzyme 
and the non-phosphorylated peptides. 
Salts of phosphopeptides, which 
have dietetic uses 
Humans (enteral 
formulas) 
E 
U
S
4
,4
9
5
,1
7
6
 
[B
ru
le
 e
t 
al
.,
 
1
9
8
5
] 
Phosphopeptides from 
casein-based raw 
material 
CPP (organophosphorated salts) 
from NaCN or paracasein  
Enzymatic hydrolysis (Pancreatin  in the form of a 
natural pancreatic extract, or a mixture of trypsin and 
-chymotrypsin) of NaCN or paracasein. 
Membrane separation (UF) and aggregation (bivalent 
cation salt) to isolate phosphopeptides from the 
proteolytic enzyme and the non-phosphorylated 
peptides.  
Phosphopeptide salts (calcium 
and/or magnesium and/or 
oligoelements such as iron and 
zinc) dietetic uses. 
Humans (enteral 
formulas) 
E 
U
S
 4
,8
1
6
,3
9
8
 
[B
ru
le
 e
t 
al
.,
 
1
9
8
9
] 
Casein phosphopeptide 
composition 
Casein phosphopeptide 
composition (< 4% 
phenylalanine, tyrosine and 
tryptophan, > 8% and < 20% 
serine, ratio of Ca+Mg+P/total 
nitrogen > 0.2  and free amino 
acids < 3%). 
Enzymatic hydrolysis of casein (Pancreatin in the 
form of a natural pancreatic extract or a mixture of 
trypsin and -chymotrypsin)  
Membrane separation (UF) and aggregation with a 
bivalent cation salt to isolate phosphopeptides. 
Aliment for dietetic or 
therapeutic nutrition or 
medicament.  
Humans E 
U
S
5
,0
2
8
,5
8
9
 
[B
ru
le
 e
t 
al
.,
 1
9
9
1
] Casein phosphopeptide 
salts 
Casein phosphopeptide salts of 
calcium, magnesium or both (< 
4% by weight of aromatic 
amino acids, >8% and <20% by 
weight serine; <3% free amino 
acid; total calcium, magnesium 
and phosphorus to total nitrogen 
> 0.2.) 
NaCN or paracasein enzymatic hydrolysis 
(pancreatin in the form of a natural pancreatic extract 
or a mixture of trypsin and -chymotrypsin)  
Membrane separation (UF) and aggregation with a 
bivalent cation salt to isolate phosphopeptides. 
Aliment for dietetic or 
therapeutic nutrition and 
medicines 
Humans (enteral 
formulas) 
E 
U
S
5
,2
1
6
,1
2
3
[
B
ru
le
 e
t 
al
.,
 
1
9
9
3
b
] 
Non-phosphorylated 
peptides from casein-
based material 
Non phosphorylated peptides 
and phosphopeptides   
Enzymatic hydrolysis (Pancreatin in the form of a 
natural pancreatic extent or a mixture of trypsin and 
-chymotrypsin)  
Membrane separation (UF) and aggregation with a 
bivalent cation salt to isolate the non-phosphorylated 
fraction. 
Phosphopeptides form salts, 
which have dietetic uses, with 
macroelements such as calcium 
and/or magnesium and/or 
oligoelements such as iron and 
zinc. 
Humans (enteral 
formulas) 
E 
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U
S
5
,2
1
9
,7
3
5
 
[B
ru
le
 e
t 
al
.,
 
1
9
9
3
a]
 
Non-phosphorylated 
peptides from casein-
based material 
Non phosphorylated peptides 
and phosphopeptides 
Casein based material (skimmed milk) enzymatic 
hydrolysis with Pancreatin. 
Membrane separation (UF) and disaggregation 
(acidification) to isolate the non-phosphorylated 
fraction. 
Phosphopeptides form salts, 
which have dietetic uses, with 
macroelements such as calcium 
and/or magnesium and/or 
oligoelements such as iron and 
zinc 
Humans (enteral 
formulas) 
E 
U
S
5
,3
3
4
,4
0
8
 
[B
ru
le
 e
t 
al
.,
 
1
9
9
4
b
] 
Nutrient composition 
containing non-
phosphorylated peptides 
from casein-based 
material 
Non-phosphorylated peptides Casein-based material (NaCN, caseinomacropeptide) 
enzymatic hydrolysis (Pancreatin in the form of a 
natural pancreatic extract or a mixture of trypsin and 
chymotrypsin). 
Membrane separation (UF) and aggregation with a 
bivalent cation salt to isolate the non-phosphorylated 
fraction. 
Non-phosphorylated peptides 
(compositions for providing 
nutrition) and phosphopeptides 
salts (dietetic uses) 
Nutrition 
formulas 
(enteral 
formulas) 
E 
U
S
5
,3
5
2
,4
7
6
 
[B
ru
le
 e
t 
al
.,
 
1
9
9
4
a]
 
Nutrient composition 
containing non-
phosphorylated peptides 
from casein-based 
material 
Non-phosphorylated peptides Casein based material (skim milk) enzymatic 
hydrolysis (Pancreatin, chymotrypsin, trypsin) of a 
casein-based material (skim milk) 
Membrane separation (UF) and disaggregation (acid 
or calcium complexant) to isolate the non-
phosphorylated fraction. 
Non-phosphorylated peptides 
and phosphopeptides useful as 
alimentary products or 
medicaments 
Nutrition 
compositions 
for providing 
nutrition. 
E 
U
S
5
,2
9
0
,6
8
5
 [
K
o
id
e 
et
 a
l.
, 
1
9
9
4
] 
Method for separation 
and concentration of 
phosphopeptides  
Method for separating and 
concentrating acidic peptides, 
especially phosphopeptides 
having a phosphoserine residue 
Casein (acid casein, sodium caseinate and calcium 
caseinate) enzymatic hydrolysis with protease 
(trypsin, pepsin, chymotrypsin or papain) 
Cross-linkage of the CPP on chitosan beads. 
Desorption of the CPP at pH < 1.5 or > 5.  
CPPs for use as ingredients in 
food materials, functional foods, 
nutrients, etc. 
- E 
U
S
5
,7
8
0
,5
9
3
 [
L
ih
m
e 
et
 a
l.
, 
1
9
9
8
] 
Method of isolating 
biomolecules by ion 
exchange 
Ion-exchange method for the 
isolation of CPPs 
Casein hydrolysates (trypsin) 
Membrane separation (UF) followed by anion 
exchange chromatography 
Prevention of osteoporosis 
(food, feed, health-care product, 
cosmetic or pharmaceutical 
products) 
Adults E 
U
S
5
,4
0
5
,7
5
6
 
[N
ai
to
 e
t 
al
.,
 
1
9
9
5
] 
Transparent acid drink 
containing acid-soluble 
casein phosphopeptide 
Transparent, storage, stable 
acidic (pH  3) beverage or 
other alimentary product 
containing a mixture of  and -
CPPs 
Casein (NaCN) trypsin hydrolysis 
Precipitation of CPPs (acid, Fe
2+
, Ca
2+
, BaCl) or 
extraction with active carbon.  
Addition of CPP to a mixture to produce a beverage 
or product having beneficial solubilising effects on 
calcium 
Food to increase absorption by 
the human body of calcium and 
iron for growing infants and 
children, treatment of anaemia 
(women), and osteoporosis 
(aged people). Lactose 
intolerants 
Infants, women 
and old people 
F 
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U
S
7
,0
6
0
,4
7
2
 [
H
o
lt
, 
2
0
0
6
] 
Calcium phosphate 
nanoclusters and their 
applications 
Particles of calcium phosphate 
nanoclusters coupled with CPP, 
with high calcium 
concentrations 
Whole casein enzymatic hydrolysis (protease XIV 
and papain Type IV) or s1-casein enzymatic 
hydrolysis (tryptic digest) 
Membrane separation (UF). 
Treatment of teeth 
demineralisation 
Broad F 
U
S
7
,9
6
8
,5
1
3
 
B
2
 [
Is
co
v
ic
h
 
et
 a
l.
, 
2
0
1
1
] 
Pharmaceutical 
compositions comprising 
casein derived peptides 
and methods of use 
thereof 
Pharmaceutical compositions 
with casein-derived peptides in 
the format of a clear sterile 
solution. 
Generation of casein hydrolysates with trypsin or 
pancreatic extracts. Microfiltration of casein 
hydrolysate yielding a mixture of low-molecular 
weight [1- 5 kDa] peptides derived from , s1 and 
s2-casein. 
Therapeutical amounts of CPPs 
for the management of lactating 
animals to decrease length of 
the dry period, increase milk 
yield and hygiene, and prevent 
mammary gland infection.  
Lactating 
animals (dairy 
herds) and 
humans 
F 
U
S
6
,1
8
0
,7
6
1
 [
H
an
 
an
d
 S
h
in
, 
2
0
0
1
b
] 
Casein from Korean 
cattle 
New CPP obtained from a novel 
casein 
Casein having a novel amino acid sequence (isolated 
from the milk of Korean cattle with a β-casein A1 H 
genotype). 
Enzymatic hydrolysis with trypsin, no further 
extraction of the CPP formed. 
Solubilisation and promotion of 
mineral absorption (infant 
formulas, lactose intolerants, 
osteoporosis and anaemia) 
Infants and 
adults 
S 
U
S
5
,8
3
4
,4
2
7
 [
H
an
 
an
d
 S
h
in
, 
2
0
0
1
a]
 
Casein phosphopeptide, 
casein containing same 
and process for the 
preparation thereof 
Purified novel -casein H 
derived CPP with a novel AA 
sequence. 
Bovine milk hydrolysed with trypsin 
Extraction of -casein H CPP by anion exchange, 
cation exchange, precipitation by ferric ions and gel 
filtration chromatography 
Improved ability for solubilising 
minerals and absorption. 
Human nutrition 
for calcium 
absorption 
S 
U
S
0
0
9
6
7
4
1
A
1
 
[S
la
tt
er
y
 
an
d
 
L
eo
n
o
ra
, 
2
0
0
3
] 
Enhanced mineral 
delivery 
CPPs from -casein complexed 
with minerals 
CPPs with Xaa-Ser(P)-Ser(P)-Glu-Glu sequences 
produced by genetic recombination or organic 
synthesis. CPP complexed with minerals 
Bone density improvement and 
oral formulas 
Oral and bone 
health 
O 
U
S
2
0
0
3
0
1
9
5
1
5
0
 A
1
 
[R
ey
n
o
ld
s 
et
 a
l.
, 
2
0
0
9
] 
Antimicrobial peptides Non-glycosylated antimicrobial 
peptides, less than 100 amino 
acids. 
Casein hydrolysed with trypsin or rennet. 
Precipitation at pH 4.6. centrifugation and peak 
collection (semi-preparative HPLC) 
Antimicrobial for oral hygiene Oral hygiene O 
U
S
5
.0
1
5
.6
2
8
 
[R
ey
n
o
ld
s,
 
1
9
9
1
] 
Anticariogenic 
phosphopeptides 
Phosphopeptides with caries and 
gingivitis inhibition properties 
Treatment of bone diseases and 
mineral malabsorption 
Casein hydrolysed by trypsin. 
Purification of CPPs with ion exchange 
chromatography followed by UF or selective 
precipitation of CPPs followed by dialysis 
Food-grade remineralising and 
antimicrobial phosphopeptides 
Oral hygiene O 
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U
S
0
0
7
5
6
7
5
 
A
1
 
[R
ey
n
o
ld
s,
 
2
0
0
8
c]
 
Stabilised calcium 
phosphate complexes 
CPP-ACP or CPP-ACFP 
complexes formed at pH 
between 5.0 and 7.0 
Oral composition containing 
about 2% of CPP-ACP or CPP-
ACFP 
Tryptic digest of casein+ ACP or ACFP 
Microfiltration (0.1m filters) to remove salts and 
inactive peptides. 
Treatment or prevention of 
dental caries, tooth enamel 
remineralisation, prevention of 
dental calculus, dentinal 
hypersensitivity dental erosion 
and corrosion. 
Oral hygiene O 
U
S
6
8
3
6
8
8
 B
2
 
[D
ix
o
n
 a
n
d
 
K
am
in
sk
y
, 
2
0
0
5
] 
Stable oral compositions 
comprising casein 
phosphopeptide 
complexes and fluoride 
Compositions with fluoride, 
CPP-ACP and calcium chelators 
Method of maintaining fluoride levels in an oral care 
composition (decrease of fluoride concentration in 
the product by the use by date <20% compared to the 
fresh product) with a safe an effective amount of 
caseinophosphopeptides., fluoride and calcium 
chelator 
Remineralisation and/or 
recrystallisation of enamel and 
dentin surfaces for the treatment 
of dental caries 
Oral hygiene O 
U
S
 
6
,7
8
0
,8
4
4
 
[R
ey
n
o
ld
s,
 
2
0
0
4
] 
Calcium phosphopeptide 
complexes 
Method for making complexes 
of ACP and ACFP stabilised by 
phosphopeptides 
Casein hydrolysed with trypsin at pH 9.0 
Mixing with Ca
2+
, Pi and F at pH 9.0 
Filtering and drying of the complexes formed 
Anticariogenic, remineralisation 
of tooth surface and dietary 
supplements with increased 
calcium bioavailability. 
Oral hygiene O 
U
S
0
0
6
3
9
2
2
A
1
 
[R
ey
n
o
ld
s 
an
d
 T
y
as
, 
2
0
0
5
] 
Dental restorative 
materials 
Composition for restorative 
materials (CPP-ACP and CPP-
ACFP complexes) 
Composition for dental restorative materials (glass 
ionomer cement, composite material) containing 
CPP-ACP or CPP-ACFP 
Treatment and prevention of 
oral caries 
Oral hygiene O 
U
S
 
6
,4
4
8
,3
7
4
B
1
 
[R
ey
n
o
ld
s,
 
2
0
0
2
] 
Production of 
phosphopeptides from 
caseins 
Method for preparation of 
anticariogenic phosphopeptides 
ranging from 10,000 to 20,000 
Da 
Casein hydrolysed with trypsin  
UF and DF 
Anticariogenic phosphopeptides Oral hygiene  O 
U
S
 
5
,2
2
7
,1
5
4
 
[R
ey
n
o
ld
s,
 
1
9
9
3
] 
Phosphopeptides for the 
treatment of dental 
calculus 
CPPs (zinc/phosphopeptide 
complexes or aggregates) 
Method for inhibiting dental calculus using oral 
compositions containing CPP salts with phosphatase 
inhibitors 
Casein digest with proteolytic enzymes  
Inhibition of dental calculus Oral hygiene  O 
U
S
5
,9
8
1
,4
7
5
 
[R
ey
n
o
ld
s,
 
1
9
9
9
] 
Treatment for sensitive 
teeth 
Oral composition for treatment 
of dentinal hypersensitivity 
Oral composition containing specific 
phosphoproteins and phosphopeptides derived from 
caseins 
Desensitizing of teeth using 
CPPs 
Oral hygiene O 
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UF: ultrafiltration 
DF: diafiltration 
CPP: Caseinophosphopeptide 
NaCN: sodium caseinate 
ACP: Amorphous calcium phosphate 
ACFP: Amorphous calcium fluoride phosphate 
E: extraction methodology 
O: oral hygiene 
F: formulation 
S: new sequences 
U
S
0
,1
9
3
,5
5
7
 
[R
ey
n
o
ld
s,
 
2
0
0
8
a]
 
Dental mineralisation  Dental mineralisation with 
amorphous calcium phosphate 
(ACP) or amorphous calcium 
fluoride phosphate (ACFP) 
stabilised by CPPs  
Method for mineralising dental surface or subsurface 
using a protein disrupting agent (bleach, detergent, 
chaotropic agent or protease) application followed 
by the application of complexes of amorphous 
calcium phosphate (ACP) or amorphous calcium 
fluoride phosphate (ACFP) and CPPs  
Mineralising a dental surface or 
subsurface 
Oral hygiene  O 
E
P
 2
 3
4
3
 
3
1
4
 A
2
 
[R
ey
n
o
ld
s,
 
2
0
1
1
] 
Calcium fluoride 
phosphopeptide 
complexes  
Stable complexes of amorphous 
calcium fluoride phosphates 
stabilised by phosphopeptides.  
Tryptic digest of casein 
Isoelectric precipitation (pH4.6) and microfiltration 
to isolate CPPs 
Formation of CPP-ACFP complexes by addition of 
CaCl2, NaH2PO4 and NaF to the CPPs at pH>7 
Anti-cariogenic complexes with 
potential applications as dietary 
supplements. 
Oral hygiene, 
supplements, 
pharmaceutical 
compositions 
O 
U
S
0
2
9
7
2
0
3
 [
T
an
cr
ed
l 
et
 a
l.
, 
2
0
1
0
] 
Impact of calcium 
phosphate complex on 
dental caries 
Chewing gum and confectionary 
compositions to reduce dental 
caries  
Chewing gum or confectionary containing at least 
3% (w/w) CPP-ACP, acting as an anticaries agent. 
CPP-ACP can be encapsulated to allow gradual 
release in center-filled gums or confectionaries. 
Slowing down the progression 
and enhancing the regression of 
dental caries. The composition 
may reduce caries formation by 
16.9% compared to product free 
of CPP-ACP. 
Increase in acid resistance > 4% 
and increase in remineralisation 
(at least by 10%).  
Oral hygiene O 
U
S
0
2
1
5
5
9
3
 A
1
 
[R
ey
n
o
ld
s,
 2
0
1
0
] 
Ionic complexes Methods of making superloaded 
phosphoprotein stabilized ACP 
or ACFP complexes with 
anticariogenic properties with a 
calcium content higher than 
30mol/CPP mol 
Blending CPP-ACP (or CPP-ACFP) with at least an 
equal amount of calcium phosphate (in the form of 
CaHPO4) at pH  < 7 
 
Anticariogenic complexes for 
remineralisation of dental 
surfaces/ subsurfaces  
Method for treatment and /or 
prevention of dental caries, 
erosion, corrosion, 
hypersensitivity and dental 
calculus 
Oral hygiene 
Dietary 
supplements 
O 
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Table 3 
Product type Manufacturer Format Application 
Ingredients    
CE90CPP DMV, International ingredient - 
Lacprodan D1-2021 Arla Foods ingredient Improves oral hygiene and 
uptake of vitamins and 
minerals.  
Peptigen 110 MD Foods ingredient - 
Capolac Arla Foods ingredient Helps mineral absorption 
CPPB and CPPC  Armor Proteins ingredient - 
CPP-I, II & III Meiji Seika ingredient - 
Recaldent Cadbury Adams ingredient - 
Food products    
Tekkotsu Inryou Suntory soft drink Helps mineral absorption 
Kotsu Calcium Asahi soft drink Helps mineral absorption 
Meiji Milk Recaldent Meiji milk beverage Maintains strong teeth 
Oral hygiene products    
Trident white sugar gum Cadbury gum (with 
Recaldent) 
Actively strengthens & 
rebuilds teeth with Recaldent 
Recaldent Mints Cadbury mints - 
MI Paste (ProspecTM MI Paste/GC 
Tooth Mousse
a
)  
MI Paste Plus (GC Tooth Mousse 
Plus
a
) 
GC 
GC 
tooth paste (with 
Recaldent) 
Helps remineralize and 
rejuvenate teeth and reduces 
dental erosion 
Topacal C-5
b
 Nulite Systems 
International  
Dental cream  - 
Phoscal
b
 Nulite Systems 
International 
- - 
a
 commercial name outside of the USA, Canada and Japan; 
b
 no longer commercially available 
-: details not available 
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Table 4 
Active ingredient Mechanism of action  Particle 
size (nm) 
Commercial 
ingredient/product 
Fluoride  Inhibition of demineralization 
 Enhancement of remineralisation (deposition of aggregates of calcium fluoride at the tooth 
surface) 
 Inhibition of bacterial enzymes 
41 Most commercial toothpastes 
Triclacium phosphate   Slightly increases levels of calcium in the plaque and saliva  
 Some issues with its bioavailability (formation of calcium phosphate and calcium fluoride 
complexes) 
10-5000 Cerasorb® 
Bio-Resorb® 
Dicalcium phosphate 
dehydrate 
 Increases levels of free calcium in the plaque fluid - Used in combination with 
fluoride pastes 
Calcium glass  Reduction in supragingival plaque 
 Reduction in gingival bleeding 
 Bioavailability of calcium and phosphate may be low 
- Novamin
TM
  
 
Calcium salts  Desensitization of sensitive cervical dentin 
 Issue with unstabilised calcium and phosphate (formation of insoluble calcium phosphate 
precipitates) 
- Enamelon
TM
  
ACP  Hydrolyses at pH 7.4 to form octacalcium phosphate then surface apatite  
 Desensitizing effects  
 Improvement of surface defects of surface enamel 
 Not a remineralising agent on its own  
- - 
CPP-ACP  Remineralises enamel subsurface lesions (Product formed following remineralisation= 
hydroxyapatite) 
 Suppresses demineralisation 
 Increases levels of calcium in the dental plaque and inhibits fermentation  
 Buffering action in the plaque by providing calcium and phosphate ions 
 Binds Streptococcus mutans impairing their incorporation in the dental plaque 
 Anticalculus action (prevents calcium precipitation) 
 Causes the regression of white spot lesions 
1.5 Recaldent
TM
 (GC Tooth Mousse, 
MI Paste) 
CPP-ACFP  Similar effects as CPP-ACP with a synergistic effect of fluoride  
 Greater remineralisation than CPP-ACP below pH 5.5 
 Product formed following remineralisation= fluoroapatite 
2.1 Combination of GC Tooth 
Mousse or MI Paste with a 
fluoride toothpaste 
CPP: caseinophosphopeptide 
ACP: amorphous calcium phosphate 
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ACFP: amorphous calcium fluoride phosphate 
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Table 5 
Product tested Number of participants Duration  Results Reference 
Test group: Mouthrinse with (1) 2 % CPP-ACP Recaldent
TM
 
(2) 6 % CPP-ACP Recaldent
TM
 (3) unstabilised slurry of 
calcium and sodium phosphate  
Control group: deionised water 
 
30 adults 5 days  Increase in Ca and Pi level of in the plaque in a 
dose dependant manner. CPP-ACP localised at 
the bacteria surface and in the intercellular 
plaque matrix.  
[Reynolds et 
al., 2003] 
Test group: sugar-free chewing gum Recaldent
TM
 pellet gum 
containing 9.5 mg of CPP-ACP 
Control group: none 
30 adults 4 days Increase in CPP level in the plaque. 132 ng of 
CPP/mg plaque (25 % of this amount still 
present in the plaque 3 h after gum chewing). 
 
Test group: 3 months treatment with  
CPP-ACP paste without fluoride (Topacal C5) + 3 months 
fluorinated toothpaste 
Control group: 6 months 0.05 % NaF mouth wash  + fluoride 
toothpaste (1000-1100 ppm) 
 
26 adolescents 6 months (12 months 
follow-up) 
63 % WSL sites totally disappear with the 
CPP-ACP treatment vs. 25 % for the control 
after 12  months (55 and 18 %, respectively, 
after 6 months) 
[Andersson 
et al., 2007] 
Test group: microabrasion of WSL followed by CPP-ACP 
paste (Tooth Mousse) application (15 min, twice daily) 
Control group: none 
Not disclosed Up to several 
months (not 
specified) 
Natural tooth appearance recovered with 
elimination of superficial WSL. 
[Ardu et al., 
2007] 
Test group: (1) mouth rinse (Recaldent
TM
) with 2 % CPP-
ACP + 450 ppm fluoride and (2) mouth rinse with 450 ppm 
fluoride 
Control group: deionised water 
14 adults 5 days  Plaque fluoride level doubled with the fluoride 
mouth rinse as compared to the control. 
Plaque fluoride level with the 2 % CPP-ACP + 
fluoride mouth rinse more than two times that 
obtained with the fluoride mouthrinse. 
[Reynolds et 
al., 2008] 
Test group: sugar free gum containing 54 mg CPP-ACP 
Control group: sorbitol-based sugar-free gum 
2720 adolescents 24 months 18 % reduction in approximal caries and 53 % 
greater regression with the CPP-ACP group as 
compared to the control group. 
[Morgan et 
al., 2008] 
Test group: Tooth cream with 10 % CPP-ACP (Tooth 
Mousse/ MI Paste)  + fluoride toothpaste (1100 ppm) and 
mouth rinse (900 ppm) 
Control group: placebo cream  + fluoride toothpaste (1100 
ppm) and mouth rinse (900 ppm) 
45 adolescents (post 
orthodontic population) 
12 weeks  31 % more regression of the WSL as compared 
to the control 
[Bailey et 
al., 2009] 
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Test groups: Tooth Mousse topical application after tooth 
brushing 
Control group: none 
10 orthodontic patients  
(average age 17.7 years) 
2 months follow-up Reduction of enamel demineralisation of 
WSEL 
[Zhou et al., 
2009] 
Test groups: (1) Toothpaste with 2 % CPP and (2) Toothpaste 
with 1190 ppm Fluoride and 0.76 % sodium 
monofluorophosphate (SMFP) 
Control group: Placebo toothpaste without CPP 
150 adolescents 24 months Regression of caries as compared to the control 
group. 
No significant differences of decayed surface 
of the carious lesions in the CPP group and the 
SMFP group. 
[Rao et al., 
2009] 
Test group: Tooth Mousse in combination with fluoride 
toothpaste  
Control group: fluoride toothpaste 
60 adolescents  4 weeks No significant difference in the regression of 
WSL between the test and the control groups 
[Brochner et 
al., 2011] 
Test group: CPP-ACP (10 % (w/w) - MI paste) + non-fluoride 
toothpaste 
Control group: none 
8 adults 24 months Increase of the pH of WSEL during 24 months 
(from 5.94 to 6.70) toward that of sound 
enamel  
Visual improvement of the appearance of 
WSEL 
[Kitasako et 
al., 2010] 
Test group: CPP-ACP (0.2 % (w/w)) paste (Recaldent
TM
 GC 
Tooth Mousse) applied with fluoride trays without rinsing 
Control group: healthy premolar of the same subjects studied 
 
30 children (6 to 9 years) 
with Molar Incisor 
Hypomineralisation (MIH) 
3 years 
4 months follow-up 
More geometric, mature and Mineralised MIH.  
Increase in the potential MIH enamel structure. 
[Baroni and 
Marchionni, 
2011] 
Test group: CPP-ACP (Tooth Mousse) + sodium fluoride 
(1450 ppm F) toothpaste 
Control group: sodium fluoride (1450 ppm F) toothpaste 
26 adults (22-31 years) 3 weeks Significant reduction of laser fluorescence in 
the CPP-ACP group after 15 days, compared 
to the control group. Reduction of the enamel 
surface porosity in the CPP-ACP group. 
No difference between the 2 group while 
performing a visual analysis of the fissures. 
[Altenburger 
et al., 2010] 
Test group: CPP-ACP (Tooth Mousse) + sodium fluoride 
topical gel 
Control group: no agent applied on the tooth surface 
21 adolescents (13-17 years) 60 days Prevention of demineralisation of the enamel 
around orthodontic brackets with CPP-ACP 
and fluoride. No significant difference between 
CPP-ACP and fluoride. 
[Uysal et al., 
2010] 
Test group: CPP-ACP (0.2 % (w/w)) + sodium fluoride (900 
ppm) paste (MI Paste plus) in combination with fluoride 
toothpaste 
Control group: fluoride-free control paste (Ultradent) in 
combination with fluoride toothpaste 
54 orthodontic adolescents 
after debonding 
12 weeks (follow-up 
3 months) 
No significant change in the size of the WSL 
between the 2 groups 
Decrease in the percentage of aciduric bacteria 
from 47.4 to 38.1 % and S. mutans from 9.6 to 
6.6 % 
No advantage of CPP-ACFP paste in addition 
to normal oral hygiene. 
[Beerens et 
al., 2010] 
Test group: CPP-ACP (MI Paste) applied after teeth brushing 60 orthodontic adolescents 3 months Reduction of enamel decalcification index [Robertson 
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with a fluoride paste 
Control group: placebo fluoride paste 
score by 53.5 % with MI Paste.  
Reduction of the number of WSL and 
protective effect of CPP-ACFP 
et al., 2011] 
Test group: CPP-ACP (Tooth Mousse) on demineralised teeth 
Control group: placebo gel on demineralised teeth/ sound and 
demineralised teeth with no topical  treatment 
40 adolescents (10-16 years) 1 month Formation of an amorphous layer on 
demineralised teeth following CPP-ACP 
treatment. 
[Ferrazzano 
et al., 2011] 
CPP: caseinophosphopeptide 
ACP: amorphous calcium phosphate 
ACFP: amorphous calcium fluoride phosphate 
SMFP: sodium monofluorophosphate 
MIH: molar incisor hypomineralisation 
RCT: randomised control trial 
WSL: white spot lesions  
WSEL: white spot enamel lesions 
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List of figures 
 
Figure 1. Peptide sequence of tryptic caseinophosphopeptides from s1-casein f(59-
79)5P and -casein f(1-25)4P highlighting the “acidic motif”(fragment underlined) 
 
Figure 2. Schematic representation of the extraction procedure of 
caseinophosphopeptides (CPPs) (adapted from Reynolds [1991]) 
 
Figure 3. The possible sites of action of caseinophosphopeptides (CPPs) in vivo 
 
Figure 4. Schematic representation of caseinophosphopeptide-amorphous calcium 
phosphate (CPP-ACP) complex manufacture (adapted from Reynolds [2008c]) 
 
Figure 5. Summary of the bioactive properties of caseinophosphopeptide-amorphous 
calcium phosphate (CPP-ACP) in the oral cavity 
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Figure 1 
 
 
 
 
 
  
s1-casein f(59-79)5P
Gln-Met-Glu-Ala-Glu-Ser(P)-Ile-Ser(P)-Ser(P)-Ser(P)-Glu-Glu-Ile-Val-Pro-Asn-Ser(P)-Val-Glu-Gln-Lys
-casein f(1-25)4P
Arg-Glu-Leu-Glu-Glu-Leu-Asn-Val-Pro-Gly-Glu-Ile-Val-Glu-Ser(P)-Leu-Ser(P)-Ser(P)-Ser(P)-Glu-Glu-Ser-Ile-Thr-Arg
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Figure 2 
 
 
 
  
Tryptic hydrolysis of 
sodium caseinate
pH  adjustment 
to 4.7
0.1M HCl
Precipitate Supernatant
BaCl2
+ Ethanol
PrecipitateSupernatant
pH  adjustment 
to 3.5
1M HCl
Acetone
PrecipitateSupernatant
pH  adjustment to 
2.0
HCl solution
Precipitate Supernatant
pH  adjustment to 
3.5
NaOH solution
+ acetone
PrecipitateSupernatant
H2SO4 solution 
Precipitate Supernatant
Dialysis
Spray drying
CPP powder
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Figure 3 
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Figure 4 
 
 
 
 
Tryptic hydrolysate 
of casein
pH adjustment from 
7.0 to 5.0
l.25M Na2HPO4
Permeate Retentate
3.25M CaCl2
1M NaOH
Filtration (0.1m 
filter)
Wash with water 
 2
Permeate
(Salt, inactive 
peptides )
Retentate
(CPP)
Filtration (0.1m 
filter)
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Figure 5 
  
CPP: caseinophosphopeptide 
ACP: amorphous calcium phosphate 
PDL: periodontal ligament 
SBS: shear bond strength 
CPP-ACP
Carriers:
- oral hygiene products
- adjuncts for the oral hygiene
- foods
- Stabilisation of CaPO4 solution  (increased solubility 
of Ca and Pi)
- Increased concentration of Ca and Pi in the saliva
- Increased bioavailability (low dissociation constant)
- Biomineralisation: localisation of ACP and crystal 
growth promoter at the tooth surface
- Maintain supersaturated state of Ca and Pi at the tooth 
surface
- Remineralisation at the surface and inside of the lesion 
Remineralising agent 
- Buffering capacity (prevention of 
hydroxyapatite dissolution)
- More acid resistant remineralised enamel 
compared to normal enamel 
Prevention of demineralisation
- Reduction of dentin hypersensitivity 
- Preimplantation medium of  PDL cells 
for alvusion injury (at low concentration)
- Modification of SBS (increased?)
Other bioactivitiesAnti-plaque action
- Direct binding of CPP-ACP to plaque 
bacteria surface
- Reduction of Ca and Pi  diffusion in the 
plaque 
- Half-life of CPP-ACP in the plaque >2h 
- Buffering capacity 
